Clinical trial register · China

Clinical Trials in China

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV

Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 07 Nov 2026, 03:17 UTC

19187

Studies in scope

all four open statuses

11790

Recruiting now

open to new participants

2028

Lead sponsors

across recruiting studies

Top sites

Beijing 5576 Shanghai 3879 Guangzhou 3345 Hangzhou 1819 Wuhan 1343

Trials in this register

Status

Study

Lead sponsor

Phase

Enrol

Chinese sites

Start

Recruiting

A Study of D-2570 in Patients With Active Systemic Lupus Erythematosus (SLE)

NCT07311200Active Systemic Lupus Erythematosus

DrugD-2570

InventisBio Co., Ltd

Phase 2

120

Linfen

2026-02-12

Recruiting

A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors

NCT07466160Solid Tumor

Drugs7MW3711·JS207·Cisplatin·Carboplatin

Mabwell (Shanghai) Bioscience Co., Ltd.

Phase 1/2

280

Shanghai

2026-02-11

Active, closed

Pembrolizumab + MRGOO3 as Neoadjuvant in NPC

NCT07267338NPC, Locoregionally Advanced Nasopharyngeal Carcinoma

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 2

Wuhan

2026-02-11

Recruiting

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

NCT07363694Moderate to Severe Chronic Obstructive Pulmonary Disease

Pfizer

Phase 2/3

1,156

Chizhou, Fuyang, Hefei, Beijing, Chongqing, Guangzhou, Huizhou, Xinxiang

2026-02-11

Recruiting

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

NCT07432295Solid Tumor, Advanced Cancer, Metastatic Cancer, Gastric Cancer

DrugsGivastomig·5Fluorouracil·Leucovorin·Adrucil

I-Mab Biopharma US Limited

Phase 2

180

Beijing

2026-02-11

Recruiting

Thyroid Cartilage Plane VS Superior Laryngeal Nerve Space Block in Awake Tracheal Intubation

NCT07397234Superior Laryngeal Nerve Block

Nanjing First Hospital, Nanjing Medical University

Not applicable

Nanjing

2026-02-11

By invitation

Innovative Probe With Laser on Radial Artery Puncture and Catheterisation in Paediatric

NCT07454005Radial Artery Catheterization, Paediatric, Ultrasound Guided

The First Hospital of Jilin University

Not applicable

408

Changchun

2026-02-11

Not yet open

Rezvilutamide for High-Risk Prostate Cancer After Surgery

NCT07444983Prostate Cancer (Adenocarcinoma)

Fujian Medical University Union Hospital

Not applicable

Fuzhou

2026-02-11

Active, closed

Ultra-stable Iodized Oil-Chemo Embolization Seq Thermal Ablation in Early Liver Ca

NCT07493070Hepatocellular Carcinoma (HCC)

Fujian Medical University Union Hospital

Not applicable

Fuzhou

2026-02-10

Recruiting

Becotatug Vedotin for LA-NPC With a Suboptimal Response to Induction Chemotherapy Combined With Immunotherapy

NCT07496190Nasopharyngeal Cancinoma (NPC)

DrugBecotatug Vedotin

Sun Yat-sen University

Phase 2

Guangzhou

2026-02-10

Recruiting

Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis

NCT07335887AL Amyloidosis (AL), t(11;14) Positive

DrugsSonrotoclax·Daratumumab·Dexamethasone

Peking University People's Hospital

Phase 2

Beijing, Xi'an

2026-02-10

Recruiting

Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy

NCT07400523Breast Cancer

DrugRibociclib

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 3

446

Zhanjiang, Guangzhou, Shantou

2026-02-10

Recruiting

A Phase II Trial Comparing Immunotherapy Versus Capecitabine Maintenance After Chemo-chemoradiotherapy for High-risk Nasopharyngeal Carcinoma

NCT07392320Nasopharangeal Cancer

DrugsCCRT·Serplulimab·Capecitabine

Sun Yat-sen University

Phase 2

142

Guangzhou

2026-02-10

Recruiting

IBI354 With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer

NCT07377643HER2-positive Breast Cancer

DrugsIBI354·Pertuzumab·Trastuzumab·Docetaxel

Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.

Phase 3

540

Beijing

2026-02-10

Recruiting

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

NCT07369011Sleep Apnea, Obstructive, Obesity, Overweight

DrugEloralintide

Eli Lilly and Company

Phase 3

800

Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hefei, Kunming

2026-02-10

Recruiting

Flow Diverter Versus Conventional Endovascular Treatment for Unruptured Wide-Neck Bifurcation Aneurysms (FD-BWA Trial)

NCT07707076Unruptured Intracranial Wide-neck Bifurcation Aneurysms

Nanfang Hospital, Southern Medical University

Not applicable

266

Guangzhou

2026-02-10

Recruiting

NWRD09 for Persistent Cervical HPV16 Infection

NCT07710703Persistent Cervical HPV16 Infection

Newish Biotech (Wuxi) Co., Ltd.

Not applicable

Beijing

2026-02-10

Recruiting

Thiotepa in Combination With Pirtobrutinib (a BTK Inhibitor) and Sintilimab (a PD-1 Inhibitor) for Frail or Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma

NCT07416890Pirtobrutinib, Sintilimab, Central Nervous System Lymphoma

Zhejiang Cancer Hospital

Phase 2

Hangzhou

2026-02-10

Recruiting

A Study of Brenipatide in Adult Participants With Schizophrenia

NCT07410507Schizophrenia

DrugBrenipatide

Eli Lilly and Company

Phase 2

450

Changsha, Chengdu, Hangzhou, Suzhou, Tianjin, Wuhu, Xi'an, Zhumadian

2026-02-10

Not yet open

Intravascular Imaging-Guided Intravascular Lithotripsy for Severe Coronary Calcified Lesions.

NCT07444346Coronary Artery Calcification, Coronary Artery Disease

The First Affiliated Hospital with Nanjing Medical University

Observational

200

Nanjing

2026-02-10

Recruiting

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

NCT07392190Overweight, Obesity

DrugEloralintide

Eli Lilly and Company

Phase 3

900

Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Guiyang, Hefei, Huzhou

2026-02-10

Recruiting

Neoadjuvant Chemoradiotherapy Plus Tislelizumab With or Without Probio-M9 in pMMR/MSS Locally Advanced Rectal Cancer

NCT07458529Rectal Cancer, Adenocarcinoma, Neoadjuvant Therapy, Immunotherapy, Probio-M9

Seventh Medical Center of PLA General Hospital

Phase 2

Beijing

2026-02-10

Not yet open

Assessing Hydromorphone Sustained-Release Tablets in Elderly Cancer Pain Patients With Renal Insufficiency

NCT07421674Cancer Pain, Renal Insufficiency Chronic, Hydromorphone Use

Taian Cancer Hospital

Observational

Tai’an

2026-02-10

Not yet open

Research Proposal on the Effects of Different Altitude Conditions on Human Time Perception.

NCT07402148Heart Rate Monitoring

Qilu Hospital of Shandong University

Observational

Jinan

2026-02-10

Not yet open

Phase 2 Clinical Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Platinum Chemotherapy Versus Platinum Chemotherapy in the Treatment of Second-/Third-line Triple Negative Breast Cancer (TNBC)

NCT07413601Triple Negative Breast Cancer Metastatic

DrugsCisplatin/Carboplatin·Lenvatinib

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2

Beijing

2026-02-10

Recruiting

Correlating EEG Dynamics With Consciousness Alteration Under Anesthesia

NCT07410702Altered State of Consciousness, General Anesthetics

Huazhong University of Science and Technology

Observational

250

Wuhan

2026-02-10

Recruiting

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

NCT07227415Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma, Renal Cancer, Renal Neoplasm

DrugsCasdatifan·PF-08634404·Axitinib·Yervoy

Pfizer

Phase 1/2

224

Beijing, Chongqing, Wuhan, Changsha, Nanjing, Jinan, Ningbo

2026-02-10

Not yet open

Individualized Open Lung Ventilation and Postoperative Pulmonary Complications in Thoracic Surgery

NCT07387822Postoperative Pulmonary Complications (PPCs), One-lung Ventilation (OLV), Thoracic Surgery, Video Assisted

Aerospace Center Hospital

Not applicable

352

Beijing

2026-02-10

By invitation

Early Postoperative Intervention in Gastric Cancer Patients

NCT07444099Gastric Cancer (GC), Postoperative Recovery

Qilu Hospital of Shandong University

Not applicable

264

Jinan

2026-02-10

Recruiting

Study on the Treatment of HER2-negative Breast Cancer Brain Metastases With Radiotherapy Combined With Anlotinib

NCT07396454HER2-Negative Breast Cancer

The First Affiliated Hospital with Nanjing Medical University

Phase 2

Nanjing

2026-02-10

Not yet open

ctDNA Monitoring Guides the Treatment of NSCLC With Befotertinib Combined With Radiotherapy

NCT07410611Patients With Advanced Oligometastatic Non-small Cell Lung Cancer (NSCLC) Who Have Tested Positive for EGFR Mutations Confirmed by Histopathological Examination

DrugBefotertinib

Hebei Medical University Fourth Hospital

Phase 2

Shijiazhuang

2026-02-10

Recruiting

Remimazolam for Bronchoscopy in High-Risk Patients

NCT07395596Pulmonary Infection, Pulmonary Nodule, Phthisis, Endotracheal Tumour

DrugRemimazolam

First Affiliated Hospital of Zhejiang University

Phase 4

360

Hangzhou, Shaoxing

2026-02-09

Recruiting

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

NCT07412756Depressive Disorder, Major

DrugBrenipatide

Eli Lilly and Company

Phase 3

1,000

Beijing, Changsha, Chaohu, Chengdu, Guangzhou, Haidian District, Hefei, Huzhou

2026-02-09

Not yet open

Effectiveness and Safety of a Type A Dissection Total Endovascular Reconstruction System in Promoting Favorable Distal Aortic Remodeling

NCT07402252Residual Dissection After Repair for Type A Aortic Dissection

West China Hospital

Not applicable

198

Chengdu

2026-02-09

Recruiting

A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy

NCT07387094OSA - Obstructive Sleep Apnea, Obesity

DrugEcnoglutide

Hangzhou Sciwind Biosciences Co., Ltd.

Phase 3

140

Beijing

2026-02-09

Recruiting

The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia

NCT07362355Primary Gout and Hyperuricemia

DrugFebuxostat

Jiangsu HengRui Medicine Co., Ltd.

Phase 2

340

Shanghai

2026-02-09

Recruiting

Study on the Prevention of Atrial Fibrillation Recurrence After Ablation by Qidong Yixin Granule

NCT07508618Persistent Atrial Fibrillation

Sir Run Run Shaw Hospital

Phase 4

846

Hangzhou, Huzhou, Ningbo

2026-02-09

Recruiting

Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.

NCT06059261Nasopharyngeal Carcinoma

Chongqing University Cancer Hospital

Phase 2

Chongqing

2026-02-09

By invitation

Safety and Efficacy of B/F/TAF in Pregnancy

NCT07666386HIV

Drug：BIC

Shi Zou

Observational

Wuhan

2026-02-09

Recruiting

Safety and Efficacy of Cryoablation for Thyroid Tumors

NCT07776262Thyroid Tumor, Thyroid Neoplasm

Yukun Luo

Not applicable

108

Beijing

2026-02-09

Recruiting

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

NCT07353931Osteoarthritis, Overweight or Obesity

DrugEloralintide

Eli Lilly and Company

Phase 3

900

Beijing, Bengbu, Changchun, Changsha, Chongqing, Hangzhou, Hefei, Jinan

2026-02-09

Recruiting

Blood Pressure Monitor (TH-75) Atrial Fibrillation Detection Function Clinical Trial

NCT07442175Atrial Fibrillation (AF)

Andon Health Co., Ltd

Observational

392

Tianjin

2026-02-09

Recruiting

Application of Precision Partial Intersphincteric Resection (PPISR)

NCT07849023Low Rectal Cancer, Rectal Cancer Patients

First Affiliated Hospital of Wenzhou Medical University

Not applicable

100

Wenzhou

2026-02-08

Active, closed

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma

NCT07266441Multiple Myeloma

DrugRamantamig

Janssen Research & Development, LLC

Phase 2

168

Beijing, Chaoyang District, Guangzhou, Shanghai

2026-02-08

Recruiting

Advancing Reperfusion Therapy for Ischemic Stroke: Perfusion-guided Endovascular Intervention for Medium Vessel Occlusion Therapy

NCT07323368Stroke Ischemic, Medium Vessel Occlusions

Beijing Tiantan Hospital

Not applicable

568

Beijing, Longzhou, Luoyang, Panlong, Changle

2026-02-08

Recruiting

The Value of Super-resolution Ultrasound Imaging for Peripheral Artery Disease

NCT07374601Peripheral Artery Disease

Peking University First Hospital

Observational

300

Beijing

2026-02-08

Active, closed

Study of TRDC002 in the Diagnosis of Patients With PSMA-positive Prostate Cancer

NCT07236112Prostate Cancer

C Ray Therapeutics

Phase 1

Wuhan, Jinan

2026-02-08

Recruiting

PD-1 Inhibitor Combined With Rituximab, Methotrexate, and Orelabrutinib (PD-1i+RMO) for Newly Diagnosed PCNSL and SCNSL.

NCT07410520Primary Central Nervous System Lymphoma (PCNSL), Secondary Central Nervous System Lymphoma (SCNSL)

DrugsOrelabrutinib·Methotrexate·Rituximab

The First Affiliated Hospital with Nanjing Medical University

Phase 2

Nanjing

2026-02-07

Recruiting

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

NCT07321886Obesity, Overweight

DrugEloralintide

Eli Lilly and Company

Phase 3

1,980

Beijing, Chengdu, Guangzhou, Hefei, Jinan, Luoyang Shi, Nanchang, Nanjing

2026-02-06

Recruiting

Becotatug Vedotin (MRG003) in Combination With PD-1 Inhibitor Versus PD-1 Inhibitor for the Treatment of EGFR-positive, CPS≥1 Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT07524452Locally Advanced Head and Neck Squamous Cell Carcinoma

DrugAdjuvant Cisplatin

Ming-Yuan Chen

Phase 3

430

Zhuhai

2026-02-06

Recruiting

Efficacy and Safety of SBRT Combined With Becotatug Vedotin (MRG003) in EGFR-Positive Metastatic Tumor Patients With Oligometastases

NCT07481799Oligo-metastatic Cancer

DrugBecotatug Vedotin

Ming-Yuan Chen

Phase 3

200

Zhuhai

2026-02-06

Recruiting

A Study on the Correlation Between Tear Iron Levels and the Severity of Dry Eye Disease.

NCT07363824Dry Eye Disease, Iron

Shanghai Changzheng Hospital

Observational

Shanghai

2026-02-06

Recruiting

A Study of PLB-002 in Advanced Solid Tumors

NCT07304128Advanced Solid Tumor

Primelink BioTherapeitics(ShenZhen) Limited

Phase 1

100

Shanghai

2026-02-06

Recruiting

A Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic Dermatitis

NCT07399067Atopic Dermatitis

DrugsIBI3002·Dupilumab

Innovent Biologics (Suzhou) Co. Ltd.

Phase 2

120

Beijing

2026-02-06

Recruiting

A Dose-exploration Study of EDP167 in HoFH

NCT07489209Homozygous Familial Hypercholesterolemia (HoFH)

DrugEDP167

Eddingpharm (Zhuhai) Co., Ltd.

Phase 2

Beijing

2026-02-06

Recruiting

A Study of Rocbrutinib Versus Investigator's Choice of BTK Inhibitors in Patients With Relapsed or Refractory Mantle Cell Lymphoma

NCT07377578Mantle Cell Lymphoma

DrugsRocbrutinib·Ibrutinib·Acalabrutinib·Orelabrutinib

Guangzhou Lupeng Pharmaceutical Company LTD.

Phase 3

394

Beijing, Nanning

2026-02-05

Recruiting

Early Neurovascular Decoupling Trajectories After Revascularization in Acute Ischemic Stroke

NCT07405762Ischemic Stroke

Xijing Hospital

Observational

180

Xi'an

2026-02-05

Recruiting

Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC)

NCT07401199Gastric Cancer (GC), Locally Advanced Gastric Cancer

Qun Zhao

Observational

2,000

Fuyang, Cangzhou, Hengshui, Xingtai, Wuhan, Yichang, Baoding, Shijiazhuang

2026-02-05

Recruiting

A Phase II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Subjects With Advanced Lung Cancer

NCT07253142Non Small Cell Lung Cancer, Small Cell Lung Cancer

DrugsHLX43 2·HLX43 1·Serplulimab

Shanghai Henlius Biotech

Phase 2

120

Hefei, Fu'zhou, Guangzhou, Nanning, Cangzhou, Harbin, Xinxiang, Wuha

2026-02-05

Recruiting

Study of Single and Multiple Ascending Doses of KR23343 in Healthy Adult Participants

NCT07409922Healthy

Jiangxi Kvvit Pharmaceutical Co., Ltd.

Phase 1

Shanghai

2026-02-05

Recruiting

An Antibody-armored Dendritic Cell in Patients With Solid Tumors

NCT07479667Solid Cancers, Adjuvant Therapy

Shanghai Cell Therapy Group Co.,Ltd

Phase 1

Shanghai

2026-02-05

Recruiting

A Study of MIL116 in Healthy Participants and Patients With IgA Nephropathy.

NCT07375758Immunoglobulin A Nephropathy

Beijing Mabworks Biotech Co., Ltd.

Phase 1/2

130

Beijing

2026-02-05

Recruiting

Comparison of Serplulimab Versus Nivolumab in Neoadjuvant Therapy for Resectable Stage II-IIIA Squamous NSCLC

NCT07398937Resectable Stage II-IIIa Squamous NSCLC

DrugsSerplulimab·Nivolumab

Fudan University

Phase 2

116

Shanghai

2026-02-05

Not yet open

A Multi-modal Integrating Imaging and Cell-free DNA Methylation in Lung Cancer Early Detection (CMe-Lung): a Multi-center, Observational Study

NCT07375979Lung Cancer

Shanghai Pulmonary Hospital, Shanghai, China

Observational

14,300

Shijiazhuang, Zhengzhou, Changchun, Shenyang, Shanghai, Kunming

2026-02-05

Active, closed

A Dose Finding Study of IBI3016 in Mild to Moderate Hypertensive Patients

NCT07352969Hypertension

DrugIBI3016

Innovent Biologics (Suzhou) Co. Ltd.

Phase 2

352

Beijing

2026-02-05

Recruiting

Effect of Irrigation Pressure on Postoperative Complications and Surgical Field Clarity in Unilateral Biportal Endoscopic Surgery

NCT07837427Lumbar Disc Herniation, Lumbar Spinal Stenosis, Lumbar Degenerative Disease

Fan Zhang

Not applicable

Kunming

2026-02-05

Recruiting

TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD

NCT07487363Atherosclerotic Cardiovascular Diseases, Endothelial Dysfunction

Hudson Biotech

Phase 1/2

Shenzhen

2026-02-05

By invitation

An Investigation Into the Application of Preputial Grafts for the Reconstruction of Complex Ureteral Strictures

NCT07408050Ureteral Stenosis

Ruibao chen

Not applicable

Wuhan

2026-02-05

Not yet open

IBI363 as Neoadjuvant Therapy in Resectable Stage II-III Non-Small Cell Lung Cancer

NCT07402070Resectable Stage II-III Non-small Cell Lung Cancer

DrugLenvatinib

Innovent Biologics (Suzhou) Co. Ltd.

Phase 2

Beijing

2026-02-04

Recruiting

Autologous CAR-T Cell Therapy for Refractory and Relapsing Ulcerative Colitis: A Single-Center Exploratory Study

NCT07435779UC

DrugBcma Car-T

Hebei Senlang Biotechnology Inc., Ltd.

Early Phase 1

Guangzhou

2026-02-04

Recruiting

Clinical Study of AFN50 Injection in the Autoimmune Diseases

NCT07408336Autoimmune Diseases

AlphaNa Bioscience Company Limited

Early Phase 1

Hefei

2026-02-04

Recruiting

High-flow Nasal Cannula Versus Conventional Oxygen During Awake Tracheal Intubation With Difficult Airways

NCT07384494Awake Tracheal Intubation, Difficult Airway

Wenxian Li

Not applicable

336

Wuwei, Shenzhen, Baoding, Pizhou, Shanghai, Neijiang

2026-02-04

Active, closed

Predicting Pathological Complete Response in Rectal Cancer Using Machine Learning

NCT07509632Rectal Cancers, Pathological Complete Response, Neoadjuvant Chemoradiotherapy, Machine Learning

Peking University People's Hospital

Observational

320

Beijing

2026-02-04

Recruiting

Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16)

NCT07480954Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Carcinoma, Recurrent or Refractory Disease After Standard Therapies

Beijing Biotech

Phase 1/2

Shenzhen

2026-02-04

Recruiting

A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

NCT07276958Healthy, Systemic Lupus Erythematosus, Rheumatoid Arthritis

Eli Lilly and Company

Phase 1

Beijing, Changsha, Hefei, Shanghai, Wenzhou, Wuhan

2026-02-04

Recruiting

Phase IIa Clinical Trial of YN001 in Patients With Atherosclerotic Cardiovascular and Cerebrovascular Diseases and Erectile Dysfunction

NCT07311330Atherosclerotic Cardiovascular Disease (ASCVD), Erectile Dysfunction

Beijing Inno Medicine Co., Ltd.

Phase 2

Beijing

2026-02-04

Recruiting

Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN)

NCT07290270Metastatic Prostate Cancer

Novartis Pharmaceuticals

Observational

170

Shanghai

2026-02-04

Recruiting

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

NCT07258511Multiple Myeloma

DrugsRamantamig·Teclistamab

Janssen Research & Development, LLC

Phase 3

400

Beijing, Chengdu, Guangzhou, Hangzhou, Nanjing, Nanning, Shanghai, Wenzhou

2026-02-04

Recruiting

Efficacy and Influencing Factors of Mindfulness-Based Exposure Group Therapy for OCD

NCT07484750Obessive-Compulsive Disorder

Shanghai Mental Health Center

Not applicable

Shanghai

2026-02-03

Recruiting

Safety and Efficacy Study of PUMCH-E111 Injection in Subjects With RLBP1 Related Inherited Retinal Dystrophy

NCT07656753Inherited Retinal Dystrophy, Inherited Retinal Disease

Peking Union Medical College Hospital

Early Phase 1

Beijing

2026-02-03

By invitation

CHU Dual-Energy Ablation in Ventricular Arrhythmia

NCT07503769Premature Ventricular Contractions, Ventricular Tachycardia

Shanghai MicroPort EP MedTech Co., Ltd.

Not applicable

Ningbo

2026-02-03

Recruiting

UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases

NCT07441525Autoimmune Hemolytic Anemia, Primary Immune Thrombocytopenic Purpura, Evans Syndrome

DrugCART

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Early Phase 1

Wuhan

2026-02-03

Recruiting

A Study for HSK47388 in Participants With Ulcerative Colitis

NCT07335055Ulcerative Colitis (UC)

DrugHSK47388

Haisco Pharmaceutical Group Co., Ltd.

Phase 2

150

Hangzhou

2026-02-03

Recruiting

Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and Vomiting

NCT07208305Nausea, Vomiting

DrugsMetoclopramide·Olanzapine

Affiliated Hospital of Qinghai University

Phase 3

222

Xining

2026-02-03

Recruiting

A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis

NCT07193589Atopic Dermatitis

Chengdu Zenitar Biomedical Technology Co., Ltd

Phase 2

111

Chengdu

2026-02-03

Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

NCT07431281Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Esophageal Cancer

DrugsSonesitatug Vedotin·Zolbetuximab·Rilvegostomig·Leucovorin

AstraZeneca

Phase 3

2,130

Beijing, Changde, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin

2026-02-03

Recruiting

CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCL

NCT07397832Diffuse Large B-Cell Lymphoma (DLBCL)

DrugsPolatuzumab Vedotin·Chidamide·Rituximab

Tianjin Medical University Cancer Institute and Hospital

Phase 2

Tianjin

2026-02-03

Recruiting

Fecal Microbiota Transplantation for Ulcerative Colitis Using Dai and Han Donors

NCT07814456Ulcerative Colitis (UC), Inflammatory Bowel Disease

DrugFecal Microbiota Transplantation

First Affiliated Hospital of Kunming Medical University

Phase 2

200

Kunming

2026-02-03

Recruiting

A Study of BL-M07D1 in Combination With Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic HER2-Overexpressing Non-Squamous NSCLC

NCT07264816Non-squamous Non-small Cell Lung Cancer

DrugsT-Bren·Pembrolizumab

Sichuan Baili Pharmaceutical Co., Ltd.

Phase 2

Wuhan

2026-02-03

Recruiting

Arch-Clamping Technique Under Mild Hypothermia in Treating With Acute Type A Aortic Dissection

NCT07150559Acute Type A Aortic Dissection, Hypothermia, Total Aortic Arch Replacement, Frozen Elephant Trunk

Beijing Anzhen Hospital

Not applicable

306

Beijing

2026-02-03

Recruiting

PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC

NCT07332247Nasopharangeal Cancer, Recurrent Nasopharynx Carcinoma

Sun Yat-sen University

Phase 2

Guangzhou

2026-02-03

Recruiting

A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer

NCT07325136Relapsed/Refractory Small Cell Lung Cancer

DrugPumitamig

Bristol-Myers Squibb

Phase 1/2

240

Beijing, Shanghai

2026-02-03

By invitation

Neurofeedback Training of Anterior Insula Activity Based on Unidimensional vs. Multidimensional Interoceptive Regulation Strategies

NCT07416370Healthy

University of Electronic Science and Technology of China

Not applicable

Chengdu

2026-02-02

Recruiting

Telemedicine-supported Management for Acute Ischemic Stroke

NCT07302971Acute Ischemic Stroke

Capital Medical University

Not applicable

2,400

Beijing

2026-02-02

Not yet open

Correlation Between EIT-based Pulse Wave Method for Pulmonary Perfusion Monitoring and Pulmonary Artery Catheter-based Stroke Volume Measurement

NCT07385963Shock, Acute Respiratory Distress Syndrome

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Observational

Wuhan

2026-02-02

Recruiting

Neoadjuvant Trastuzumab Deruxtecan (SHR-A1811) + Pertuzumab in HER2+ Breast Cancer

NCT07393425HER2 + Breast Cancer

DrugsPyrotinib·Pertuzumab·Trastuzumab deruxtecan·Trastuzumab

Shanghai Jiao Tong University School of Medicine

Phase 2

Shanghai

2026-02-02

Recruiting

Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma

NCT07480941Glioblastoma, High-grade Glioma, Malignant Glioma, Recurrent Glioblastoma

DrugsFludarabine·Cyclophosphamide

Beijing Biotech

Phase 1

Shenzhen

2026-02-02

Recruiting

Dual-target CD70/CAIX CAR-NK Cells for Advanced Clear Cell Renal Cell Carcinoma

NCT07551349Advanced or Metastatic Clear Cell Renal Cell Carcinoma

DrugFludarabine

Beijing Biotech

Phase 1/2

Shenzhen

2026-02-02

Recruiting

Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo

NCT07437560NonSegmental Vitiligo, Nonsegmental Vitiligo (Stable)

Hudson Biotech

Phase 2

Shenzhen

2026-02-02

Recruiting

Y-4 to Treat the Postherpetic Neuralgia

NCT07275762Postherpetic Neuralgia, Y-4, Pregabalin

DrugsY-4 tables·Pregabalin

Neurodawn Pharmaceutical Co., Ltd.

Phase 2

160

Nanjing

2026-02-02

Recruiting

Dual-Targeting CAR-NK Cells in Biomarker-Selected Advanced Colorectal Cancer

NCT07589517Colorectal Cancer, Metastatic Colorectal Adenocarcinoma, Unresectable Colorectal Cancer

DrugEB-DUO-CAR-NK-CEA/GCC

Beijing Biotech

Phase 1/2

Shenzhen

2026-02-02

Recruiting

Dual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

NCT07480928Pancreatic Ductal Adenocarcinoma (PDAC), Unresectable Locally Advanced or Metastatic Disease

DrugMUC1)

Beijing Biotech

Phase 1/2

Shenzhen

2026-02-02

Recruiting

Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC

NCT07467863Non-Small Cell Lung Cancer, Advanced/Metastatic NSCLC

Beijing Biotech

Phase 1/2

Shenzhen

2026-02-02

Recruiting

Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)

NCT07486089Breast Cancer (Locally Advanced or Metastatic), HER2-positive Breast Cancer, Triple-Negative Breast Cancer (TNBC)

DrugEb-Dt-Car-Nk

Beijing Biotech

Phase 1/2

Shenzhen

2026-02-02

Recruiting

Study of Radiotherapy Combined With Cisplatin/Carboplatin, Adebrelimab and Bevacizumab in the Treatment of TNBC-BM.

NCT07638852TNBC, Triple Negative Breast Cancer, Brain Metastasases

DrugsAdebelimab·Bevacizumab·Cisplatin·Carboplatin

Fudan University

Phase 2

Shanghai

2026-02-02

Recruiting

MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity

NCT07505745Prediabetes, Insulin Resistance, Overweight/Obesity

Hudson Biotech

Phase 2

120

Shenzhen

2026-02-02

Recruiting

Impact of Mindfulness on Athletic Performance and Functional Movement in Collegiate Athletes

NCT07342816Athletic Performance, Mental Health

University of Macau

Not applicable

126

2026-02-02

Recruiting

BPC 157 for Acute Hamstring Muscle Strain Repair

NCT07437547Hamstring Muscle Strain, Skeletal Muscle Injury

Hudson Biotech

Phase 2

120

Shenzhen

2026-02-02

Recruiting

A Phase III Study Comparing HRS-4357 With Novel Androgen Receptor Pathway Inhibitors in Patients With Progressive, PSMA-Positive Metastatic Castration-Resistant Prostate Cancer

NCT07311694PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer

Jiangsu HengRui Medicine Co., Ltd.

Phase 3

370

Shanghai

2026-02-02

Recruiting

A Study of GR1803 in Systemic Lupus Erythematosus

NCT07348055Systemic Lupus Erthematosus, Auto Immune Disease

DrugVelinotamig specified on specified days

Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Phase 1/2

Wuhan

2026-02-02

Recruiting

Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)

NCT07481747Obesity, Overweight (Without Type 2 Diabetes) With Weight-related Comorbidities

DrugTirzepatide

Hudson Biotech

Phase 3

2,539

Shenzhen

2026-02-02

Recruiting

Acetaminophen-Mannitol Injection and Postoperative Delirium

NCT07235995Postoperative Delirium

Xiangya Hospital of Central South University

Phase 4

1,092

Changsha

2026-02-02

Recruiting

Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)

NCT07480213Small Cell Lung Cancer (SCLC), Relapsed/Refractory SCLC, SCLC, Extensive Stage

DrugEB-DART-NK01

Beijing Biotech

Phase 1/2

Shenzhen

2026-02-02

Recruiting

Guangdong Provincial Endometriosis Clinical Research Cohort

NCT07749053Endometriosis

Li Li

Observational

716

Guangzhou

2026-02-02

Recruiting

Efficacy and Safety of YD0743 Treatment for Sepsis-Associated ARDS

NCT07413094Sepsis

Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.

Phase 2

309

Beijing

2026-02-02

Recruiting

Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC

NCT07510802Breast Cancer (Advanced/Metastatic), HER2-positive Breast Cancer, Triple-negative Breast Cancer

Beijing Biotech

Phase 1/2

Shenzhen

2026-02-02

Not yet open

Efficacy and Safety of LP-005 Injection in Patients With Complement-Mediated Kidney Disease

NCT07363265Complement-mediated Renal Diseases

DrugLP-005

Longbio Pharma

Phase 2

Beijing

2026-02-02

Recruiting

Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)

NCT07481734Metabolic Associated Steatotic Liver Disease, Nonalcoholic Steatohepatitis, Hepatic Steatosis

Hudson Biotech

Phase 2

120

Shenzhen

2026-02-02

Recruiting

Topical GHK-Cu Gel for Acute Skin Wound Healing

NCT07437586Acute Standardized Cutaneous Wounds (Punch-biopsy Wounds)

Hudson Biotech

Phase 2

Shenzhen

2026-02-02

Not yet open

FAD Subtype-Guided Combination Therapy for Unresectable Hepatocellular Carcinoma

NCT07314372Unresectable Hepatocellular Carcinoma (HCC), Hepatocellular Carcinoma (HCC), Liver Cancer Adult

DrugsCamrelizumab and apatinib·TACE·Apatinib·Camrelizumab

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 2

Nanjing

2026-02-01

Recruiting

A Study on the Accurate Evaluation of Pseudoprogression of Rectal Cancer Immunotherapy Based on Multitemporal and Multiparameter MRI

NCT07381322Rectal Cancer

Peiyi Xie

Observational

300

Guangzhou, Maoming

2026-02-01

Not yet open

Cerebral Arteriovenous Malformation With Aneurysm: Epidemiology, Clinical Features, and Prognosis

NCT07353736Cerebral Arteriovenous Malformation, Intracranial Arterial Diseases, Intra Cerebral Hemorrhage, Intracranial Aneurysm

Duan Chuanzhi

Observational

630

Guangzhou

2026-02-01

Recruiting

A Phase II Study of Sacituzumab Tirumotecan in Combination With Furmonertinib in Patients With Non-squamous Non-Small Cell Lung Cancer Who Have Progressed After EGFR-TKI and Platinum-Based Chemotherapy

NCT07548060NSCLC Stage IV, EGFR Gene Mutation

DrugsFurmonertinib·Sacituzumab tirumotecan

Tianjin Medical University Cancer Institute and Hospital

Phase 2

Tianjin

2026-02-01

Active, closed

Human Umbilical Cord-mesenchymal Stem Cells Via Different Transplantation Routes in ESLD

NCT06984497End-Stage Liver Diseases

General Hospital of Shenyang Military Region

Not applicable

Shenyang

2026-02-01

Recruiting

Neoadjuvant Therapy With Tislelizumab for dMMR/MSI-H Stage II-III Colorectal Cancer

NCT07352280Colo-rectal Cancer (dMMR/MSI-H CRC)

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Observational

Beijing

2026-02-01

Not yet open

7-day High-Dose Vonoprazan-amoxicillin Dual Therapy Versus 14-day Vonoprazan-amoxicillin Dual Therapy for H. Pylori

NCT07352098Helicobacter

Yueyue Li

Not applicable

290

Kashgar

2026-02-01

Not yet open

Pleurodesis in Small-bore Chest Tube

NCT07208409Pleural Effusion, Malignant

The University of Hong Kong

Not applicable

Hong Kong

2026-02-01

Recruiting

The Value of Bowel Sounds in Evaluating Postoperative Intestinal Function Recovery in Colorectal Cancer Patients

NCT07705139Bowel Sounds, Colorectal Cancer, Intestinal Obstruction, Postoperative Ileus

Zhongnan Hospital

Observational

172

Wuhan

2026-02-01

Recruiting

Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)

NCT07383818HR Positive/HER2 Low Breast Cancer

DrugToripalimab

First Affiliated Hospital of Zhejiang University

Phase 2

111

Harbin, Hefei, Shanghai, Xi'an, Zhengzhou

2026-02-01

By invitation

Small Vessel Disease and Cerebral Infarct Healing InErvation Via Limb Distant Adaptation

NCT07503301Stroke, Small Vessel Cerebrovascular Disease

Second Affiliated Hospital, Zhejiang University, School of Medicine

Not applicable

Hangzhou

2026-02-01

By invitation

The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic Leukemia

NCT07515430Acute Lymphoblastic Leukemia

Sun Yat-sen University

Observational

138

Guangzhou

2026-02-01

Not yet open

Robotic vs Laparoscopic Gastrectomy for cT4a Gastric Cancer

NCT07331454Gastric Cancer (GC)

The First Affiliated Hospital with Nanjing Medical University

Phase 3

335

Nanjing

2026-02-01

Not yet open

Ultrasound-guided Non-invasive Simulation in Anesthesia Residency Training

NCT07385885Ultrasound, Needle, Residency, Anesthesiology

Nanjing First Hospital, Nanjing Medical University

Not applicable

Nanjin

2026-02-01

Not yet open

Validation of the Accuracy of an AI-Based System for Diagnosing Anxiety Disorders

NCT07311655Anxiety Disorders

Shanghai Mental Health Center

Observational

100

Shanghai

2026-02-01

Recruiting

Efficacy of Montelukast on STEMl Patients

NCT07320625Myocardial Infarction (MI)

DrugMontelukast

Shanghai Zhongshan Hospital

Phase 3

512

Dalian, Shanghai, Fuzhou, Guangdong, Ha’erbin, Hefei, Hunan, Shenyang

2026-02-01

By invitation

Clinical Efficacy of Exoskeleton Robot-Assisted Rehabilitation on Lower Limb Functional Recovery in Elderly Patients With Hip Fracture

NCT07323147Hip Fracture, Geriatrics, Lower Extremity Dysfunction, Postoperative Rehabilitation

Hai bao

Not applicable

Beijing

2026-02-01

Recruiting

A Multimodal AI Prediction Model for Complications After Transcatheter Closure of Perimembranous VSD in Children

NCT07375602Congenital Heart Disease (CHD), Ventricular Septal Defects (VSD), Cardiac Catheterization, Postoperative Complications

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Observational

5,249

Shanghai

2026-02-01

Not yet open

A Phase II Study of Anlotinib and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Lung Cancer.

NCT07307443SMARCA4-Deficient Tumor, Locally Advanced or Metastatic Lung Cancer

Zhijie Wang

Phase 2

Beijing

2026-02-01

Recruiting

5T MRI and Metabolomics-Based Hemorrhage Risk Prediction in Moyamoya Disease

NCT07781579Moyamoya Disease, Intracranial Hemorrhages, Stroke

Beijing Hospital

Observational

500

Beijing

2026-02-01

Not yet open

An Integrated Multi-omics Study on the Molecular Mechanisms of Ureteral Stricture

NCT07409870Ureteral Stricture, Ureteral Obstruction, Microbiome, Metabolomics

First Affiliated Hospital of Chongqing Medical University

Observational

120

Chongqing

2026-02-01

Not yet open

Intrapleural Bupivacaine Analgesia for Postoperative Pain Management After Minimally Invasive Video-Assisted Thoracoscopic Surgery: A Randomized Controlled Trial

NCT07393386Pain Management

DrugBupivacaine

Shanghai Pulmonary Hospital, Shanghai, China

Phase 4

249

Shanghai

2026-02-01

Recruiting

Multimodal Tongue-Pulse Information Fusion for Syndrome Diagnosis and Cohort Study in Children With Asthma

NCT07383883Asthma

Shanghai Children's Medical Center

Observational

1,000

Shanghai

2026-02-01

Not yet open

A Phase II Study of Neoadjuvant Sacituzumab Tirumotecan in Combination With Iparomlimab and Tuvonralimab in Locally Advanced Cervical Cancer

NCT07348861Cervical Cancer

DrugsIparomlimab·Sacituzumab tirumotecan

Zheng Min

Phase 2

Guangzhou

2026-02-01

Recruiting

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

NCT07410494Cancer, Breast Cancer, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (Locally Advanced or Metastatic)

DrugsAldesleukin·Fludarabine·Cyclophosphamide

Essen Biotech

Phase 1/2

Beijing

2026-02-01

Not yet open

A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer

NCT07363330Cervical Cancer, Recurrent, Metastatic

DrugsUtidelone·Toripalimab

Zhongnan Hospital

Phase 2

Wuhan

2026-02-01

Not yet open

Iparomlimab and Tuvonralimab Injection Combined With GemOX and Lenvatinib as Conversion Therapy for Initially Potentially Resectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer

NCT07263360BTC

DrugIparomlimab and Tuvonralimab

Tianjin Medical University Cancer Institute and Hospital

Phase 2

Tianjin

2026-02-01

Not yet open

Study on the Intervention Effect of Denosumab on High-Risk Patients With Osteoporotic Fractures in Type 2 Diabetes

NCT07063797Type 2 Diabetes, Osteoporosis, Fractures

DrugDenosumab

Peking Union Medical College Hospital

Not applicable

358

Beijing, Huai'an, Jiangxi, Kunshan

2026-02-01

Not yet open

The Effect of Probiotics on Gut Microbiota Changes in Healthy Chinese Adults During Short-Term European Travel: A Randomised, Double-Blind, Placebo-Controlled Clinical Trial

NCT07384260Healthy Adult

Min-Tze LIONG

Phase 2

Haidian

2026-02-01

Not yet open

Neoadjuvant Immunotherapy ± Radiotherapy in MSI-H/dMMR Locally Advanced Colorectal Cancer

NCT07403877Colorectal Cancer (MSI-H)

DrugsIpilimumab·Nivolumab

Fudan University

Phase 2

114

Shanghai

2026-02-01

Not yet open

Validation of the Accuracy of an AI-Based System for Diagnosing Depressive Disorders

NCT07311668Depressive Disorder

Shanghai Mental Health Center

Observational

100

Shanghai

2026-02-01

Not yet open

Personalized Transcranial Magnetic Stimulation (TMS) for Metabolic Dysfunction and Alcohol-Related Liver Disease

NCT07399600Liver Diseases, Alcoholic, Fatty Liver, Metabolic Syndrome

The Affiliated Hospital of Hangzhou Normal University

Not applicable

105

Hangzhou

2026-02-01

By invitation

A Speaking-Valve-Based Decannulation Protoco for Patients With a Prolonged Disorders of Consciousness

NCT07183670Prolonged Disorders of Consciousness, Tracheostomy

Hongying Jiang, MD

Observational

184

Beijing

2026-02-01

By invitation

Multifaceted Benefits of Auricular Point Sticking for IVF Patients: Psychological Well-being, Sleep, and Treatment Outcomes

NCT07409792Infertility, Female, Anxiety, Assisted Reproductive Techniques, Dyssomnias

Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University

Not applicable

178

Hangzhou

2026-02-01

Recruiting

Antibiotic Prophylaxis for Ureteroscopy With a Negative Pressure Suction Sheath

NCT07246967Urolithiasis, Antibiotics

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Not applicable

500

Shanghai

2026-02-01

Not yet open

A Prospective, Multicenter, Open-label, Single-arm Phase II Clinical Study Evaluating the Efficacy and Safety of Spatially Fractionated Radiotherapy Combined With the PraG Strategy for the Treatment of Soft Tissue Sarcoma

NCT07342322Soft Tissue Sarcoma (STS)

First Affiliated Hospital of Guangxi Medical University

Phase 2

Nanning

2026-02-01

Recruiting

Mepilex Lite Dressings for the Treatment of Acute Radiation Dermatitis of Anal Canal Skin

NCT06837831Rectal Cancer, Radiotherapy, Anal Pain, Acute Radiation Dermatitis, Anal Canal

Qianfoshan Hospital

Not applicable

274

Jinan

2026-02-01

Not yet open

Vitamin B Supplementation for Patients Undergoing Cardiovascular Surgery

NCT07348328Cardiovascular Surgical Procedures, Major Adverse Cardiovascular Events (MACE)

Nanjing Medical University

Not applicable

1,000

Shanghai, Nanjing

2026-02-01

Not yet open

Tubeless Strategy for Enhanced Recovery After Sublobar Resection

NCT07409129Pulmonary Nodules, Early Stage Lung Cancer (I and II), Thoracoscopic Surgery, Sublobar Resection

The First Affiliated Hospital of Guangzhou Medical University

Not applicable

138

Guangzhou

2026-02-01

Not yet open

Neoadjuvant Treatment of Toripalimab Combined With Nab-paclitaxel and Platinum Versus Neoadjuvant Docetaxel Combined With Cisplatin and 5-fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma

NCT06952621Esophageal Squamous Cell Carcinoma (ESCC)

Tang-Du Hospital

Phase 3

390

Xi'an

2026-02-01

Recruiting

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

NCT07410676Cancer, Sarcoma, Leukaemia, Breast Cancer (Locally Advanced or Metastatic)

DrugPembrolizumab

Essen Biotech

Phase 1/2

Beijing

2026-02-01

Recruiting

Registry for the Management of Helicobacter Pylori Infection in Shandong Province

NCT07335406HELICOBACTER PYLORI INFECTIONS

Yueyue Li

Observational

10,000

Jinan

2026-02-01

By invitation

Beta-sitosterol for Subarachnoid Hemorrhage: Mechanistic Analysis of Recovery and Therapy

NCT07457333Subarachnoid Haemorrhagic Stroke

Second Affiliated Hospital, Zhejiang University, School of Medicine

Phase 1/2

Hangzhou

2026-02-01

Recruiting

Early Sepsis Recognition Tool

NCT07397689Infection, Sepsis

KK Women's and Children's Hospital

Observational

40,000

Shanghai

2026-02-01

Recruiting

Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Dermatitis

NCT07573735Atopic Dermatitis (Eczema)

DrugBlood sampling

Zhongda Hospital

Observational

Nanjing

2026-02-01

Recruiting

Efficacy of Acupuncture-Mesalazine Combination Therapy in Ulcerative Colitis.

NCT07389824Ulcerative Colitis

Drugs5-ASA·Mesalazine

Qin Yu

Not applicable

Wuhan

2026-02-01

Recruiting

A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer

NCT07358676Small Cell Lung Cancer (SCLC), SCLC, Extensive Stage

Tianjin Medical University Cancer Institute and Hospital

Phase 2

Tianjin

2026-02-01

Recruiting

Dual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer

NCT07462650Colorectal Cancer Metastatic, Adenocarcinoma of Colon

DrugEB-DUO-CAR-NK-CEA/GCC

Beijing Biotech

Phase 1/2

Shenzhen

2026-02-01

Active, closed

Research on Real-time Proton Therapy Guidance Through Monitoring Proton Range Using All-digital PET

NCT07450560Solid Tumor

Shuanghu Yuan

Observational

Hefei

2026-02-01

Not yet open

Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study

NCT07398560Small Cell Lung Cancer

DrugAdebrelimab

The Third Affiliated Hospital of Harbin Medical University

Phase 2

Harbin

2026-02-01

Recruiting

Effects of Butylphthalide Enhanced With Tenecteplase on Neurological Function in Mild Disabling Acute Ischemic Stroke

NCT07369999Mild Disabling Acute Ischemic Stroke

Xiangya Hospital of Central South University

Phase 3

1,062

Changsha, Chang’an, Cili, Guankou, Huayuan, Lanshan, Leiyang, Pingjiang

2026-02-01

Recruiting

Biochemical Response and Clinical Outcomes in Patients With PBC

NCT07449793Primary Biliary Cholangitis (PBC), Primary Biliary Cholangitis

RenJi Hospital

Observational

3,000

Shanghai

2026-02-01

Not yet open

Clinical Study on an Artificial Intelligence-Assisted Chest Radiograph Model Based on Big Data and Deep Learning for Early Detection of Kawasaki Disease

NCT07405658Kawasaki Disease, Chest X-ray for Clinical Evaluation, Mucocutaneous Lymph Node Syndrome

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Observational

20,000

Shanghai

2026-02-01

Recruiting

A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma

NCT07389616Peripheral T Cell Lymphoma

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2/3

Shanghai

2026-02-01

Not yet open

Perioperative Ivonescimab Plus S-1 and Oxaliplatin (SOX) for Locally Advanced Gastric or GEJ Adenocarcinoma

NCT07374250Gastric Cancer, RCT

DrugsTeysuno·Ivonescimab·Oxaliplatin

Sichuan University

Phase 2

154

Chengdu

2026-02-01

Not yet open

Efficacy of S.T.O.P®KIT in Retarding Axial Length Growth in Children With Low Hyperopia

NCT07401511Children, Hyperopia

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Not applicable

180

Zhenzhou, Yantai, Shanghai

2026-02-01

Recruiting

Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study

NCT07410039Neuromyelitis Optica Spectrum Disorder Attack

DrugsIVMP·Eculizumab·IVIG

Chinese PLA General Hospital

Phase 4

200

Beijing

2026-02-01

Recruiting

Early Myocardial Dysfunction Helps Identify Severe Refractory Pediatric Lupus

NCT07425730Systemic Lupus Erythematosus (SLE)

Shanghai Jiao Tong University School of Medicine

Observational

Shanghai

2026-02-01

Recruiting

DCB vs DES for Severe Coronary Calcification After Optimal Modification Assessed by QFR

NCT07277114Coronary Calcification

Shanghai Zhongshan Hospital

Not applicable

656

Shanghai

2026-02-01

Active, closed

AI-Based Digital Therapeutics vs. Traditional Schroth Exercises for Adolescent Idiopathic Scoliosis

NCT07341633Adolescent Idiopathic Scoliosis (AIS)

Jinan University Guangzhou

Not applicable

300

Guangzhou

2026-02-01

Recruiting

Adjuvant TACE in HCC With High-risk Recurrence Factors

NCT07417397Hepatocellular Carcinoma, Adjuvant, Transarterial Chemoembolization

Guangxi Medical University

Phase 3

442

Nanning

2026-02-01

By invitation

Photolithography Microstructure Myopia Management Lenses in Preventing and Controlling Myopia in Children and Adolescents

NCT07514039Myopia, Child Myopia Progression

Shanghai Eye Disease Prevention and Treatment Center

Not applicable

252

Shanghai

2026-02-01

Not yet open

18F-FAPI PET in Cancers of Unknown Primary Site

NCT07372963Cancer of Unknown Primary Site

First Affiliated Hospital of Zhejiang University

Observational

120

Hangzhou

2026-02-01

Not yet open

18F-FAPI PET in Lung Cancer

NCT07370805Lung Cancer (Diagnosis)

First Affiliated Hospital of Zhejiang University

Observational

120

Hangzhou

2026-02-01

By invitation

Effects of Extra-fascial Interscalene Brachial Plexus Block on Diaphragmatic Function in School-Aged Children

NCT07382063Diaphragm Movement

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Not applicable

Shanghai

2026-02-01

Recruiting

Low-Dose Liposomal Amphotericin B for Invasive Fungal Infection Prophylaxis in Neutropenic Children

NCT07725263Thalassemia, Hematopoietic Stem Cell Transplantation, Neutropenia, Invasive Fungal Infections

DrugLiposomal Amphotericin B

Haikou Affiliated Hospital of Central South University Xiangya School of Medicine

Observational

Haikou

2026-02-01

Recruiting

A Single-arm Phase II Clinical Study of Camrelizumab Combined With Long-course Chemoradiotherapy for Total Neoadjuvant Therapy in Locally Advanced Low pMMR/MSS Rectal Cancer

NCT07527026Locally Advanced Rectal Cancer

DrugCamrelizumab

Chinese PLA General Hospital

Phase 2

Beijing

2026-02-01

Not yet open

Perioperative Tamsulosin for Treating Voiding Dysfunction Following Prostate Biopsy

NCT07276919Acute Urinary Retention, LUTS(Lower Urinary Tract Symptoms)

DrugTamsulosin

Peking University First Hospital

Phase 4

1,844

Beijing

2026-02-01

By invitation

Effects of Probiotics on Respiratory Tract Infections in Children: A Randomized, Placebo-Controlled Interventional Study

NCT07498127URTI

Min-Tze LIONG

Phase 2

120

Xuhui

2026-02-01

Not yet open

Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation

NCT07422701Portal Vein Thrombosis, Liver Cirrhosis

Peking University First Hospital

Observational

2,522

Beijing, Shenzhen, Hengshui, Qinhuangdao, Wuxi, Qingdao

2026-02-01

Not yet open

IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer

NCT07415525Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma

DrugIBI343

Zhejiang University

Phase 2

Hangzhou

2026-02-01

Not yet open

Objective Vascular Biomarkers as Triage for Depression in Chronic Atrophic Gastritis

NCT07319338Chronic Atrophic Gastritis, Depressive Symptoms, Depression, Gastrointestinal Diseases

China Academy of Chinese Medical Sciences

Observational

520

Beijing, Hengshui, Changzhou

2026-02-01

Not yet open

Preliminary Effectiveness and Feasibility of Transcutaneous Acupoints Electrical Stimulation on Chemotherapy-induced Peripheral Neuropathy Among Children With Acute Lymphoblastic Leukemia

NCT07319481Chemotherapy Induced Peripheral Neuropathy (CIPN)

The Hong Kong Polytechnic University

Not applicable

Zhengzhou

2026-02-01

Not yet open

Proactive Temperature Management in CRS-HIPEC for Prevention of Delirium

NCT07378371Pseudomyxoma Peritonei, Postoperative Delirium (POD)

Aerospace Center Hospital

Not applicable

174

Beijing

2026-02-01

Recruiting

Cognitive Effects of Hesperidin in Overweight/Obese Older Adults

NCT07750223Cognitive Dysfunction, Overweight and Obesity

Min Hou

Not applicable

105

Shanghai

2026-02-01

Recruiting

Support System Design for Adolescent Scoliosis Orthosis Wear

NCT07574229Adolescent Idiopathic Scoliosis (AIS), Adherence

Shanghai Jiao Tong University School of Medicine

Not applicable

Shanghai

2026-02-01

Recruiting

Comparing Different Doses of Corticosteroids in Local Infiltration Analgesia (LIA) for Total Knee Arthroplasty

NCT07337772Adrenal Cortex Hormones, Arthroplasty, Replacement, Knee, Anesthesia, Local

First Affiliated Hospital of Fujian Medical University

Not applicable

120

Fuzhou

2026-02-01

Not yet open

The Efficacy of Personalized Local Anesthetic Dosing Based on Ultrasound-Measured Nerve Cross-Sectional Area in Brachial Plexus Block: a Non-Inferiority Randomized Controlled Trial.

NCT07353047Upper Limb Surgery

Northern Jiangsu People's Hospital

Not applicable

300

Yangzhou

2026-02-01

Recruiting

A Smart Wearable Device for Monitoring Urination Function in Benign Prostatic Hyperplasia

NCT07357012Benign Prostatic Hyperplasia

Peking University Third Hospital

Observational

Beijing

2026-02-01

Recruiting

Safety of Robotic Surgery for GISTs at Special Anatomic Sites

NCT07405125Gastrointenstinal Stromal Tumor (GIST)

The First Affiliated Hospital with Nanjing Medical University

Not applicable

182

Nanjing

2026-02-01

Recruiting

Transcutaneous Electrical Nerve Stimulation (TENS) for the Treatment of Low Back Pain (LBP) in Adults

NCT07368920Low Back Pain, Paraspinal Muscles, CLBP - Chronic Low Back Pain

Xijing Hospital

Not applicable

Xi'an

2026-02-01

Not yet open

VR Training to Improve Postoperative Cognitive Function in Elderly Patients With Cerebral Small Vessel Disease Undergoing Non-Cardiac Surgery

NCT07370844Cerebral Small Vessel Disease, Postoperative Cognitive Function

Peking University Third Hospital

Not applicable

240

Beijing

2026-02-01

Active, closed

Study on the Rapid Diagnostic Value of Sudden Clap Provocation Test in Psychogenic Nonepileptic Seizures

NCT07742709Epilepsy, Psychogenic Non-epileptic Seizures

Xijing Hospital

Observational

1,000

Xian, Shanxi

2026-02-01

Not yet open

TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors

NCT07342738KRAS G12V, KRAS G12D, Solid Tumor

DrugsFludarabine·Cyclophosphamide

Sun Yat-sen University

Early Phase 1

Guangzhou

2026-02-01

Recruiting

Evaluating the Clinical Efficacy and Safety of Luspatercept Combined With Thalidomide in the Treatment of β-TDT Patients

NCT07338344Transfusion-dependent β-thalassemia Patients

DrugsThalidomide·Luspatercept

Rongrong Liu

Phase 2

Shenzhen, Baise City, Liuzhou, Yulin, Kunming, Naning

2026-02-01

Not yet open

Application of Mitoxantrone Hydrochloride Injection in Transoral Robotic Thyroid Cancer Surgery

NCT07354698Papillary Thyroid Cancer

DrugMitoxantrone

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Phase 4

114

Chongqicun

2026-02-01

Not yet open

A Prospective Comparative Study Involving Multiple Units to Evaluate the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus.

NCT07069972Systemic Lupus Erythematosus

Yipeng Liu

Observational

180

Jinan

2026-02-01

Not yet open

The Efficacy and Safety of Microbiota Transplantation Combined With Prebiotics for Treatment of Functional Constipation

NCT07386795Constipation - Functional, Chronic Constipation, Fecal Microbiota Transplantation

Peking Union Medical College Hospital

Not applicable

Beijing

2026-02-01

Recruiting

Efficacy and Safety of Zanubrutinib, Rituximab, and Lenalidomide (ZR²) in Combination With Tislelizumab for Relapsed/Refractory Follicular Lymphoma

NCT07418190Relapsed/Refractory Follicular Lymphoma

DrugsZanubrutinib·Lenalidomide·Tislelizumab·Rituximab

The First Affiliated Hospital with Nanjing Medical University

Phase 2

Nanjing

2026-02-01

Recruiting

Venetoclax Combined With Azacitidine for Consolidation Therapy in AML

NCT07425782Acute Myeloid Leukemia, Consolidation Therapy, Venentoclax, High Risk

The First Affiliated Hospital of Soochow University

Phase 2

216

Suzhou

2026-02-01

Not yet open

Application Study of 68Ga-NOTA-BCMA Nanoantibody Imaging in Multiple Myeloma

NCT07353554Multiple Myeloma (MM)

Peking Union Medical College Hospital

Not applicable

Beijing

2026-02-01

By invitation

Speaking Valve Trial vs. Capping Trial for Tracheostomy Decannulation in Prolonged Disorders of Consciousness

NCT07173634Prolonged Disorders of Consciousness

Hongying Jiang, MD

Not applicable

280

Beijing

2026-02-01

Not yet open

Dexamethasone Regimens for BPD Prevention in Preterm Infants

NCT07052201Infant, Premature, Bronchopulmonary Dysplasia (BPD)

The Children's Hospital of Zhejiang University School of Medicine

Phase 3

970

Hangzhou, Chengdu, Chongqing, Guangdong, Guangxi, Guiyang, Guizhou, Jilin City

2026-02-01

Not yet open

A Study of Postoperative Regional Nodal Radiotherapy in Intermediate-risk Breast Cancer

NCT07385365Breast Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 3

3,142

Beijing

2026-02-01

Not yet open

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

NCT07353827Intrahepatic Cholangiocarcinoma (Icc), Hepatic Arterial Infusion Chemotherapy

DrugsDonafenib·Pucotenlimab·Folfox

Sun Yat-sen University

Phase 2

Guangzhou

2026-02-01

Recruiting

Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide Probes

NCT07848243Lung Cancer (NSCLC), Cervical Squamous Cell Cancer, Melanoma (Skin Cancer), Breast Cancer

DrugFluorodeoxyglucose

Peking University Cancer Hospital & Institute

Phase 2

Beijing

2026-02-01

Not yet open

Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence (CHOICE-2)

NCT07383142Thymic Epithelial Tumor

Shanghai Zhongshan Hospital

Not applicable

202

Shanghai

2026-02-01

Recruiting

External Oblique Intercostal Plane Block for Postoperative Analgesia After Major Upper Abdominal Surgery

NCT07331441Abdominal Surgery, Postoperative Pain

Jun Zhang

Not applicable

Shanghai

2026-02-01

Not yet open

Iparomlimab and Tuvonralimab (QL1706) Combined With Standard Chemotherapy or Combined With Intraperitoneal Perfusion Chemotherapy and Olaparib as Neoadjuvant Therapy for Advanced Ovarian Cancer

NCT07407452Ovarian Cancers

DrugsOlaparib·Lenvatinib·Paclitaxel·Cisplatin

Jiangsu Cancer Institute & Hospital

Phase 2

Nanjing

2026-02-01

Recruiting

The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy) Combined With Tofacitinib and Doxycycline in Chinese Adult Patients With Mild to Moderate Erythematous Telangiectatic Rosacea

NCT07343635Erythematotelangiectatic Rosacea

DrugsDoxycycline·Tofacitinib·Hydroxychloroquine

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

Not applicable

186

Yiwu

2026-02-01

Not yet open

Clinical Study on Noninvasive Evaluation of Ivonescimab Antibody Distribution and Expression in Esophageal Cancer Patients by 89Zr-AK112 PET Imaging

NCT07440212Esophagus Cancer

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Observational

Chongqing

2026-02-01

Not yet open

Study on the Effectiveness and Safety of CLE Combined With Cryobiopsy for Diagnosis of Pulmonary Lesions

NCT07352176Pulmonary Lesion, Lung Cancer

Guangzhou Medical University

Not applicable

Guangzhou

2026-02-01

Not yet open

A Study on the Intervention Effect of Therapeutic Horticulture Based on the Healing System on Non-suicidal Self-injury in Adolescent Patients With Depression

NCT07115381Depression

Lei Huang

Not applicable

Guangzhou

2026-02

Not yet open

A Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizumab and Standard Chemotherapy as First-line Treatment for MSS/pMMR Metastatic Colorectal Cancer With BRAF V600E Mutation

NCT07229846Colorectal Cancer

DrugsMFOLFOX·Folfoxiri·Xelox·Irinotecan

Yanqiao Zhang

Phase 2

Harbin

2026-02

Not yet open

NECTAR Study: Neoadjuvant Toripalimab + 9MW2821 for Local UTUC

NCT07412171Upper Tract Urothelial Carcinoma

Drugs9MW2821·Toripalimab

Peking University Third Hospital

Phase 2

Beijing

2026-02

Recruiting

Safety and Efficacy of the RENATUS® Transcatheter Aortic Valve System for the Treatment of Severe Aortic Stenosis

NCT07414342Severe Aortic Stenosis

Beijing Balance Medical Technology Co., Ltd

Not applicable

800

Beijing

2026-02

Recruiting

Study of CD19 CAR-T Therapy for Refractory SLE

NCT07403097Systemic Lupus Erythematosus

Chongqing Precision Biotech Co., Ltd

Phase 1

Chongqing

2026-02

Recruiting

Response-Based Local Therapy for Regionally Advanced Breast Cancer

NCT07376538Breast Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2

157

Beijing

2026-02

Not yet open

IMM0306 in Combination With Lenalidomide vs Placebo in Combination With Lenalidomide in Patients With Relapsed/Refractory Follicular Lymphoma

NCT07355283Relapsed/Refractory Follicular Lymphoma

DrugsIMC-002·Lenalidomide

ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Phase 3

198

Beijing

2026-02

Not yet open

Electrocautery Resection Combined With HITHOC for Thymic Epithelial Tumors With Pleural Metastasis

NCT07328074Thymic Epithelial Tumor, Thymoma, Thymic Carcinoma, Pleural Metastasis

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Observational

Shanghai

2026-02

Not yet open

SEED-CRYO: Sequential 125I Seed Implantation Followed by Cryoablation vs Single-Modality Local Therapy in Unresectable Solid Tumors

NCT07450352Unresectable Solid Tumors

Li Min

Phase 2

150

Jinan

2026-02

Recruiting

A Multicenter Clinical Study of Combined Therapy for Unresectable Hepatocellular Carcinoma

NCT07482059Unresectable Hepatocellular Carcinoma

West China Hospital

Phase 1/2

Chengdu

2026-02

Not yet open

Iparomlimab and Tuvoraleimab Injection in Combination With Bevacizumab, Albumin-bound Paclitaxel, and Carboplatin as First- or Second-line Treatment for Patients With Advanced Acral and Mucosal Melanoma

NCT07347444Acral Melanoma, Mucosal Melanoma

DrugIparomlimab and Tuvoraleimab

Fudan University

Phase 2

Shanghai

2026-02

Not yet open

Safety and Preliminary Efficacy Evaluation of LC-K76 Plus Anti-PD-1 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

NCT07389187mCRPC

DrugTislelizumab

Shanghai Changzheng Hospital

Early Phase 1

Shanghai

2026-02

Recruiting

Clinical Study of Oncolytic Vaccinia VIrus Delivering Targeted CD19 in Vivo CAR-T/M Therapy for Refractory/Relapsed B-cell Lymphoma

NCT07398963Refractory/Relapsed B-cell Lymphoma

Second Affiliated Hospital, Zhejiang University, School of Medicine

Phase 1

Hangzhou

2026-02

Not yet open

Study of Ripertamab in Children With Frequent Relapses or Steroid-Dependent Nephrotic Syndrome

NCT07388810FRNS/SDNS, Ripertamab

Mao Jianhua

Not applicable

312

Hangzhou

2026-02

Recruiting

Exploratory Clinical Study of cCTL in Combination With Immunotherapy for Advanced Gynecologic Malignancies

NCT07434284Advanced Gynecological Cancers

Obstetrics & Gynecology Hospital of Fudan University

Early Phase 1

Shanghai

2026-02

Recruiting

Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastrointestinal Cancer

NCT07329894Gastrointestinal Cancer

DrugsTumor vaccine-induced specific T-cell·XH001

Beijing GoBroad Hospital

Phase 1

Beijing

2026-02

Not yet open

Golidocitinib for Refractory Immune-related Hematologic Toxicities of Advanced Lung Cancer

NCT07303881IrAE, Hematologic Disorder, Lung Cancer (Locally Advanced or Metastatic)

DrugGolidocitinib

The First Affiliated Hospital of Guangzhou Medical University

Phase 2

Guangzhou

2026-02

Not yet open

Scipibaimab Combined With Tislelizumab in Patients With First-Line Treatment-Failed Recurrent/Metastatic Nasopharyngeal Carcinoma

NCT07388758Nasopharyngeal Carcinoma (NPC)

DrugTislelizumab

Sun Yat-sen University

Phase 2

Guangzhou

2026-02

Not yet open

A Phase III Study to Evaluate the Efficacy and Safety of MDR-001 in Adult Participants With Overweight or Obesity (MOBILE）

NCT07274137Overweight or Obesity

DrugMDR-001

MindRank AI Ltd

Phase 3

738

Beijing, Changchun, Changde, Changsha, Datong, Dongyang, Ganzhou, Hefei

2026-02

Not yet open

Neoadjuvant Becotatug Vedotin Plus Pucotenlimab and Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT07393477Head and Neck Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma HNSCC

Sir Run Run Shaw Hospital

Phase 2

Hangzhou

2026-02

Not yet open

SHR2554 as Maintenance Therapy in Patients With Peripheral T-cell Lymphoma

NCT07347288PTCL

DrugZeprumetostat

The First Affiliated Hospital with Nanjing Medical University

Phase 2

Nanjing

2026-02

Not yet open

Safety and Efficacy Evaluation of LC-K76 in Patients With Metastatic Hormone-Sensitive Prostate Cancer

NCT07389174mHSPC, mHNPC, Prostate Cancer Adenocarcinoma

Shanghai Changzheng Hospital

Early Phase 1

Shanghai

2026-02

Not yet open

Lesion-Allocated Therapy for Multiple Metastases and Tumor-Zoned Treatment for Bulky Tumors: A Phase II Study of Iodine-125 Seed Implantation Combined With Cryoablation in High-Burden Metastatic Disease

NCT07437625High-Burden Metastatic Solid Tumors

Li Min

Phase 2

Jinan

2026-02

Not yet open

Simple Swallowing Training Program on Older Individuals in the Community

NCT07373028Dysphagia

Zeng Changhao

Not applicable

474

Suzhou, Zhenzhou

2026-02

Not yet open

Camouflaged WeChat-based Intervention for Abused Women

NCT07405528Domestic Violence, Mental Health Wellness 1

The University of Hong Kong

Not applicable

Hong Kong

2026-02

Active, closed

Ex Vivo Perfusion of Gene-Edited Porcine Livers in Patients With Severe Hepatic Failure

NCT07519005Hepatic Failure

Xijing Hospital

Early Phase 1

Xi'an

2026-01-31

Not yet open

A Phase I Platform Study of Target-Based Screened CAR-Macrophages for the Treatment of Advanced Malignant Tumors

NCT07409766Advanced Malignant Tumors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Early Phase 1

Beijing

2026-01-31

Not yet open

An Observational Study on Gastric Cancer in High-risk Individuals

NCT07438418Gastric Adenocarcinoma

Fudan University

Observational

3,000

Tongling

2026-01-31

Not yet open

A Phase I/II Study to Evaluate XNW34017 in Patients With Advanced or Metastatic Solid Tumor

NCT07327294Advanced Solid Tumors

Evopoint Biosciences Inc.

Phase 1/2

150

Guangzhou

2026-01-31

Not yet open

Integrated Clinical-molecular Risk Stratification to Early Recurrence in Colorectal Liver Metastases

NCT07391007Colorectal Liver Metastases

Fudan University

Observational

200

Shanghai

2026-01-31

Not yet open

Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided by MRD

NCT07357532Small Cell Lung Carcinoma

DrugsApatinib Mesylate·Adebrelimab

Peking University Cancer Hospital & Institute

Phase 2

Beijing

2026-01-31

Recruiting

Basilar Artery Occlusion Chinese Endovascular Registry in Patients With Large-Core Infarct

NCT07345702Basilar Artery Occlusion, Ischemic Stroke, Large Core Infarct

Xuanwu Hospital, Beijing

Observational

518

Beijing

2026-01-31

Not yet open

The Effect of Speaking Valve on Physiological Parameters With Wearable Devices

NCT07422350Tracheostomy Decannulation

Jingyi Ge

Observational

120

Beijing

2026-01-31

Recruiting

Zorifertinib With Osimertinib for NSCLC With Meningeal Progression

NCT07361705Patients With Advanced Non-small Cell Lung Cancer With Meningeal Progression After Osimertinib Treatment

DrugOsimertinib

Alpha Biopharma (Jiangsu) Co., Ltd.

Phase 1

Beijing, Shengyang, Guangzhou, Henan, Shanxi

2026-01-31

Recruiting

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

NCT06794073Carcinoma, Hepatocellular, Neoplasms, Glandular and Epithelial, Adenocarcinoma, Digestive System Neoplasms

Shanghai Zhongshan Hospital

Not applicable

Shanghai

2026-01-31

Recruiting

Study on Clinical Characteristics of Patients With Probable Alzheimer's Dementia Stratified by Blood Biomarkers

NCT07875998Alzheimer's Disease Dementia

Tianjin Anding Hospital

Observational

200

Tianjin

2026-01-31

Recruiting

Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After Lorlatinib

NCT07374614Non-Small Cell Lung Cancer, ALK, Iruplinalkib, Lorlatinib

Peking University Shenzhen Hospital

Observational

Shenzhen

2026-01-31

Active, closed

A Prospective, Randomized, Blind, Controlled Multicenter Clinical Study Comparing the Effectiveness of Preventive Ventricular Arrhythmia Ablation on the Prognosis After Left Ventricular Assist Device (LVAD) Surgery.

NCT07589738CHF - Congestive Heart Failure

The First Affiliated Hospital of Anhui Medical University

Not applicable

Hefei

2026-01-31

Not yet open

Clinical Study of Anti-CLL1-CD33-NKG2D Bicephali CAR-T for Relapsed/Refractory Acute Myeloid Leukemia

NCT07370064AML (Acute Myeloid Leukemia)

DrugCar-T

Xuzhou Medical University

Phase 1/2

Xuzhou

2026-01-31

Not yet open

Compound Granules of Hedyotis Diffusa for Chronic Atrophic Gastritis

NCT07391800Chronic Atrophic Gastritis With Hyperplasia (Diagnosis)

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Not applicable

Shanghai

2026-01-31

Recruiting

Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA

NCT07400341MDS (Myelodysplastic Syndrome), Aplastic Anemia (AA)

DrugsRecombinant Human Thrombopoietin·RhTPO·Romiplostim

The First Affiliated Hospital of Soochow University

Phase 2

Suzhou

2026-01-31

Recruiting

Eye Tracking Study on Eye Movement Function and Visual Attention Patterns in Patients With Thyroid-Associated Ophthalmopathy

NCT07381413Thyroid Associated Ophthalmopathies, Eye Tracking

Shanghai Changzheng Hospital

Observational

100

Shanghai

2026-01-31

Recruiting

Structured Active Follow-up in Postoperative Management of Thyroid

NCT07589660Patients After Thyroid Surgery

Yu Feng

Not applicable

244

Chengdu

2026-01-31

Not yet open

Development and Validation of a Cardiac Magnetic Resonance-Based Multimodal Deep Learning Model for Long-Term Outcome Prediction in ST-Segment Elevation Myocardial Infarction

NCT07277400ST Elevation (STEMI) Myocardial Infarction

Qian geng

Observational

800

Beijing

2026-01-31

Not yet open

AI-Generated Video Feedback to Improve Technical Skills in Coronary Artery Bypass Grafting

NCT07400172Cardiac, Surgery (Cardiac), Education, Artificial Intelligence (AI)

China National Center for Cardiovascular Diseases

Not applicable

100

Beijing

2026-01-31

Recruiting

Study of MCLA-129 in Combination With Ensartinib in Patients With Advanced Solid Tumors.

NCT07448116Solid Advanced Tumor

DrugsMCLA-129·Ensartinib

Betta Pharmaceuticals Co., Ltd.

Phase 1/2

164

Beijing

2026-01-31

Recruiting

Assessment of Food Intake Using Both 3D Scanning Method and a Photographic Method

NCT07371559Data Collection

Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences

Observational

200

Shenzhen

2026-01-31

Not yet open

A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer

NCT07358585Colon Cancer Adenocarcinoma

DrugsHLX43 4·HLX07·HLX43 3·HLX43 2

Shanghai Henlius Biotech

Phase 1/2

126

Guangzhou

2026-01-31

Not yet open

A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody

NCT07445815Rabies (Healthy Volunteers)

DrugRabies Vaccine

Lanzhou Institute of Biological Products Co., Ltd

Phase 2

200

Lanzhou

2026-01-31

Not yet open

Efficacy and Safety of Xeligekimab in the Treatment of Non-Radiographic Axial Spondyloarthritis

NCT07339566Nr-axial Spondyloarthritis, Non-Radiographical Axial Spondyloarthritis

DrugXeligekimab

Lingli Dong

Phase 2/3

Wuhan

2026-01-31

Not yet open

Topefilgrastim Injection in the Treatment of High-Risk Pregnant Patients With Preeclampsia

NCT07384936Preeclampsia

Fang Wang

Not applicable

100

Lanzhou

2026-01-31

Not yet open

Safety and Efficacy of CLL1 CAR-T Followed by Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

NCT07342244AML, AML (Acute Myeloid Leukemia)

Donghua Zhang

Not applicable

Wuhan

2026-01-30

Recruiting

SKB500 Combinations in Patients With Small Cell Lung Cancer

NCT07296809Small Cell Lung Cancer

DrugsSKB500·Sacituzumab tirumotecan·Etoposide·Carboplatin

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Phase 2

Guangzhou

2026-01-30

Not yet open

Robot/Laparoscopic-Assisted Transanal Transection Duhamel Versus Modified Soave Pull-Through for TCA

NCT07343622Total Colonic Aganglionosis, Hirschsprung Disease, Duhamel, Soave

Zunyi Medical College

Not applicable

Zunyi

2026-01-30

Not yet open

Integrated Study on Gut Microbiota, Immune Indicators, and Trace Elements in Children With Respiratory Tract Infections

NCT07378852Respiratory

Min-Tze LIONG

Observational

120

Lanzhou

2026-01-30

Not yet open

the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines

NCT07338851Polio, Measles, Rubella, Mumps

China National Biotec Group Company Limited

Observational

600

Suzhou, Handan, Yancheng, Hanzhong, Yuncheng, Mianyang

2026-01-30

Recruiting

Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer

NCT07392541Advanced Biliary Tract Carcinoma

DrugsSimvastatin·Adebrelimab·Gemcitabine·Cisplatin

Tongji Hospital

Phase 1/2

Wuhan

2026-01-30

Not yet open

Motor Development Assessment and Support for Children With Neurodevelopmental Disorders

NCT07323004Neurodevelopmental Disorders

Aiyoudong Children and Youth Sports Health Research Institute

Not applicable

100

Beijing

2026-01-30

Not yet open

Drug Sensitivity Testing-Based Tumor Organoids to Guide Adjuvant Therapy After Hepatectomy for Primary Liver Cancer

NCT07363356Hepatocellular Carcinoma Resectable

Eastern Hepatobiliary Surgery Hospital

Phase 2

Shanghai

2026-01-30

Not yet open

A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B.

NCT07412236Liver Fibrosis, Liver Fibrosis in Chronic Hepatitis B

DrugHydronidone

Beijing Continent Pharmaceutical Co, Ltd.

Phase 3

1,208

Shanghai

2026-01-30

Recruiting

Preop US-Guided Nerve Blocks for Pain & Recovery After Ankle Arthroscopy

NCT07470021Ankle Ligament Injury，Chronic Ankle Instability，Ankle Arthroscopy

Second Affiliated Hospital, Zhejiang University, School of Medicine

Not applicable

Hangzhou

2026-01-30

Not yet open

The Effectiveness and Safety of Artificial Intelligence(AI)-Assisted Medical Treatment Decision Support System Compared to Conventional Care in HFrEF Patients

NCT07380555Heart Failure With Reduced Ejection Fraction (HF-rEF)

Shanghai Zhongshan Hospital

Not applicable

1,200

Shanghai

2026-01-30

Recruiting

Frequency of Electrical Acupoint Stimulation on Hypotension in TAVR Patients

NCT07365345Transcatheter Aortic Valve Replacement (TAVR), Hemodynamic Stability, Anesthesia Induction, Electro-acupuncture

Air Force Military Medical University, China

Not applicable

150

Xi'an

2026-01-30

Not yet open

A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases

NCT07212322Systemic Lupus Erythematosus, Idiopahic Inflammatory Myopathies, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Sjögren's Syndrome

Institute of Hematology & Blood Diseases Hospital, China

Not applicable

Tianjin

2026-01-30

Not yet open

Head to Head, Prospective, Open Label Multicenter Study on the Diagnostic Efficacy of GPC3 Targeted PET Imaging and Enhanced Magnetic Resonance Imaging for Hepatocellular Carcinoma

NCT07352345Malignant Neoplasm of Liver

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Early Phase 1

150

Wuhan

2026-01-30

Recruiting

A Study of GC203 TIL in Advanced Solid Tumors (NF)

NCT07256756Solid Tumors, Adult

DrugEngineering Tumor Infiltrating Lymphocytes

Shanghai Juncell Therapeutics

Phase 1

Shenzhen

2026-01-30

Not yet open

Zillion: Zanubrutinib Combined With Chemotherapy for Newly Diagnosed CNS Lymphoma

NCT07405255Central Nervous System Lymphoma

DrugsZanubrutinib·Rituximab

Ruijin Hospital

Phase 2

Shanghai

2026-01-30

Recruiting

Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis

NCT07352358Cerebral Venous Thrombosis

Xuanwu Hospital, Beijing

Phase 4

Beijing

2026-01-30

Not yet open

A Study of the Pharmacokinetics and Safety of Anaprazole Sodium in Special Populations

NCT07345689Hepatic Insufficiency, Renal Insufficiency, Elderly

DrugAnaprazole Sodium enteric

Xuanzhu Biopharmaceutical Co., Ltd.

Phase 4

Changchun

2026-01-30

Recruiting

Intrauterine Injection of Type III Collage in FST of EC/AEH

NCT07377734Atypical Endometrial Hyperplasia, Endometrial Cancer

DrugProgestin

Wang Jianliu

Phase 2

Beijing

2026-01-30

Recruiting

Jiedu Huayu Oral Prescription in the Treatment of Intracranial Hemorrhage Associated With Cerebral Amyloid Angiopathy

NCT07250035Cerebral Amyloid Angiopathy

Beijing Tiantan Hospital

Phase 3

436

Beijing

2026-01-30

Recruiting

Prospective Validation of an AI Model for Predicting Liver Metastasis in Colorectal Cancer

NCT07392567Colorectal Cancer Liver Metastasis

Tongji Hospital

Observational

160

Wuhan

2026-01-30

Recruiting

Prognosis of Primary Aldosteronism: A Prospective Cohort Study

NCT07378176Primary Aldosteronism

Xinjiang Medical University

Observational

5,000

Chengdu, Ürümqi

2026-01-30

Not yet open

Efficacy and Safety of Pregabalin/Tizanidine vs. Pregabalin in Patients With Fibromyalgia

NCT07382921Fibromyalgia, Pregabalin, Pain

DrugPregabalin

Beijing Tiantan Hospital

Not applicable

164

Beijing

2026-01-30

Recruiting

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

NCT07227298Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer

DrugsSigvotatug vedotin·PF-08634404

Pfizer

Phase 1/2

162

Beijing, Fuzhou, Wuhan, Nanjing, Shanghai, Taizhou

2026-01-30

Not yet open

Preliminary Evaluation of Clinical Application of SPECT Imaging Targeting GPC3

NCT07353333HCC, SPECT-CT

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Not applicable

Wuhan

2026-01-30

Recruiting

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

NCT07288177Non-small Cell Lung Cancer (NSCLC)

DrugRina-S

Genmab

Phase 2

240

Shanghai, Beijing, Changchun, Nanjing, Tianjin, Zhangjiakou, Zhengzhou

2026-01-30

Not yet open

Isa-VRD in TIE HRMM

NCT07334535Multiple Myeloma

Peking Union Medical College Hospital

Phase 4

117

Beijing

2026-01-30

Recruiting

Platform Study of VSV-Based Recombinant Oncolytic Viruses for the Treatment of Advanced Malignant Tumors

NCT07656116Advanced Solid Tumor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 1

Langfang

2026-01-29

Recruiting

A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)

NCT07227597Small Cell Lung Cancer Extensive Stage

DrugsGocatamig·Ifinatamab Deruxtecan·Etoposide·Atezolizumab

Merck Sharp & Dohme LLC

Phase 1/2

170

Beijing, Fuzhou, Guangzhou, Jiangmen, Harbin, Nanchang, Shanghai, Chengdu

2026-01-29

Recruiting

A Phase 1/2 Study of GW5282 in Participants With Advanced Solid Tumors

NCT07328217Advanced Solid Tumors

DrugGW5282

Dizal Pharmaceuticals

Phase 1/2

203

Beijing

2026-01-29

Recruiting

Fulzerasib Sequential Sintilimab Plus Platinum-Doublet Neoadjuvant Therapy for Resectable KRAS G12C-Mutant NSCLC

NCT07492342Resectable NSCLC, KRAS G12C Mutation, Stage IB-IIIA NSCLC, Neoadjuvant Therapy

DrugsFulzerasib·Sintilimab

Jianxing He

Phase 2

Beijing, Guangzhou, Zhejiang

2026-01-29

By invitation

Research on the Pathogenesis and Therapeutic Targets of Articular Cartilage Degeneration in Osteoarthritis

NCT07796607Osteoarthritis (OA)

Yunnan University of Chinese Medicine

Observational

Kunming

2026-01-29

Recruiting

Study of the Safety, Tolerability, Pharmacokinetics of VV913 Capsules in Chinese Healthy Participants

NCT07372703Healthy Volunteers

DrugVV913 group

Vigonvita Life Sciences

Phase 1

Hefei

2026-01-29

Recruiting

In Vivo CAR-T for Refractory Graves' Disease

NCT07333677Graves' Disease

Shanghai Zhongshan Hospital

Early Phase 1

Shanghai

2026-01-29

Recruiting

Multicenter Prospective Non-randomized Controlled Study of Ella Photodynamic Therapy for Cervical HSIL/CIN2

NCT07306260HSIL, High Grade Squamous Intraepithelial Lesion, CIN 2, HPV (Human Papillomavirus)-Associated, Photodynamic Therapy (PDT)

Second Affiliated Hospital, Zhejiang University, School of Medicine

Not applicable

560

Hangzhou, Ningbo, Shaoxing

2026-01-29

Active, closed

HS-20093 in Patients With Advanced Gastric and Gastroesophageal Junction Adenocarcinoma

NCT07462923Advanced Gastric and Gastroesophageal Junction Adenocarcinoma

DrugRis-Rez

Hansoh BioMedical R&D Company

Phase 1

Beijing, Fuzhou, Xiamen, Shijiazhuang, Harbin, Zhengzhou, Wuhan, Changsha

2026-01-29

Recruiting

This is a Multi-Center Study of IBI3026 in Participants With Locally Advanced, Unresectable or Metastatic Solid Tumors

NCT07327632Solid Tumor

Innovent Biologics Technology Limited (Shanghai R&D Center)

Early Phase 1

300

Chengdu

2026-01-29

Recruiting

Exploratory Study of LP-98 for Injection in ART-Naive HIV-Infected Individuals

NCT07433387HIV

Shanxi Kangbao Biological Product Co., Ltd.

Phase 1/2

Tianjin

2026-01-29

Recruiting

A Phase III Study of GS101 Injection to Dupixent®

NCT07386743Atopic Dermatitis (AD)

DrugDupilumab

Jiangsu Genscend Biopharmaceutical Co., Ltd

Phase 3

572

Shenyang

2026-01-29

Recruiting

A Phase II Clinical Trial to Evaluate the Efficacy and Safety of FXS5626 in Patients With NIU

NCT07552012Active Non-anterior, Non-infectious Uveitis

DrugFXS5626

Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.

Phase 2

Chongqing

2026-01-29

Recruiting

Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

NCT07435038Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Advanced Solid Tumors

Betta Pharmaceuticals Co., Ltd.

Phase 1/2

120

Hangzhou

2026-01-29

Recruiting

A Clinical Study of Sintilimab Combined With Chemothrapy Versus Chemotherapy as Adjuvant Therapy for Gastric/Gastroesophageal Junction Adenocarcinoma

NCT07492615Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

DrugsS-1, Oxaliplatin·Sintilimab

Fudan University

Phase 2

276

Shanghai

2026-01-29

Recruiting

A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM)

NCT07331272Systemic Lupus Erythematosus (SLE), Idiopathic Inflammatory Myopathies(IIM)

Nanjing Legend Biotech Co.

Phase 1

Bengbu, Guangzhou, Changsha, Xuzhou, Nanchang

2026-01-29

Recruiting

Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors

NCT07505069Solid Tumors

Nanolattix Biotechnology Co., Ltd.

Early Phase 1

Wuxi

2026-01-29

Recruiting

A Study of MR001 in Patients With Locally Recurrent or Metastatic Advanced Triple-Negative Breast Cancer (TNBC)

NCT07208149Triple-Negative Breast Cancer (TNBC)

Shenzhen Majory Biotechnology Co., Ltd.

Phase 1/2

Beijing, Hubei, Hunan

2026-01-29

By invitation

Evaluation of the I-phase Clinical Trial of 177Lu-HX02 Injection in Patients With Advanced Malignant Solid Tumors

NCT07920822Soft Tissue Sarcoma, Non-small Cell Lung Cancer

Hexin (Suzhou) Pharmaceutical Technology Co., Ltd

Phase 1

Wuhan

2026-01-29

Recruiting

Evaluate the Efficacy and Safety of HMI-115 in Women With Moderate to Severe Endometriosis-associated Pain

NCT07318688Endometriosis

Hope Medicine (Nanjing) Co., Ltd

Phase 3

540

Beijing, Nanning, Suzhu, Shanghai, Tianjin

2026-01-29

Recruiting

A Clinical Study Evaluating the Efficacy and Safety of SHR-1139 Injection in Adult Patients With Ulcerative Pyoderma Gangrenosum

NCT07337564Pyoderma Gangrenosum

DrugSHR-1139

Shandong First Medical University

Phase 2

Jinan

2026-01-29

Recruiting

CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants

NCT07350837Highly Sensitized Patients Awaiting Kidney Transplant

DrugAZD0120

Tongji Hospital

Early Phase 1

Wuhan

2026-01-28

Recruiting

Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab

NCT07363642Severe Asthma

DrugTezepelumab

AstraZeneca

Phase 3

400

Beijing, Binzhou, Changsha, Chengdu, Chongqing, Deyang, Fuzhou, Guangzhou

2026-01-28

Recruiting

A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic Cancer

NCT07438106Locally Advanced Pancreatic Cancer With KRAS G12D Mutation

DrugHRS-4642

The First Affiliated Hospital with Nanjing Medical University

Phase 2

Nanjing

2026-01-28

Recruiting

Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

NCT07234019Immune Thrombocytopenia, Treatment

DrugsDaratumumab（Anti-CD38 Monoclonal Antibody）·Rituximab

Institute of Hematology & Blood Diseases Hospital, China

Phase 2

160

Tianjin

2026-01-28

Recruiting

A Study of Choydar Flow-Directed Mesh Stent in the Treatment of Unruptured Intracranial Aneurysms

NCT07228312Intracranial Aneurysm

Johnson & Johnson Medical (Shanghai) Ltd.

Observational

200

Chenzhou, Guangzhou, Nanjing, Nanyang, Taiyuan, Wuhu, Zhengzhou

2026-01-28

Not yet open

Evaluation of the Pharmacokinetics of Curcumin Capsules in Healthy Human

NCT07379177Healthy

Kingdomway (Inner Mongolia) Nutritional Food Co., Ltd.

Not applicable

Xiamen

2026-01-28

Not yet open

Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer Patients

NCT07358520Proteinuria

DrugHuaier

Fudan University

Phase 4

Xuzhou, Shanghai

2026-01-28

Recruiting

AI-Assisted Remote Insulin Pump Optimization in T1DM

NCT07732777Type 1 Diabetes Mellitus, Type 1 Diabetes (T1D)

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Not applicable

Nanjing

2026-01-28

Recruiting

A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC

NCT07385001Esophageal Squamous Cell Carcinoma, Ivonescimab, Neoadjuvant

DrugIvonescimab

Tang-Du Hospital

Phase 1/2

Xi'an

2026-01-28

Recruiting

SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer

NCT07256236Cervical Cancer

DrugsSacituzumab tirumotecan·Lenvatinib

Fujian Cancer Hospital

Phase 2

Fuzhou, Zhangzhou, Guangzhou, Nanning, Hohhot, Dalian, Jinan, Jining

2026-01-28

Not yet open

A Single-arm, Phase II, Multi-center Clinical Trial of Sintilimab During the Perioperative Period in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT07379424Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

chen chao Professor

Phase 2

Hangzhou

2026-01-28

Recruiting

A Multi-dimensional Evaluation of the Effects of Linear Accelerator X-ray Irradiation on Red Blood Cells

NCT07416045Erythrocyte Destruction

Second Affiliated Hospital, Zhejiang University, School of Medicine

Observational

Hangzhou

2026-01-28

Not yet open

Neoadjuvant Chemoimmunotherapy or Chemoradiotherapy in ESCC

NCT07385664Resectable Esophageal Cancer

Ji Yongling

Phase 2

Hangzhou

2026-01-28

Recruiting

Continuous vs. Intermittent Rt-fMRI Neurofeedback Training of the Anterior Insula

NCT07389486Healthy

University of Electronic Science and Technology of China

Not applicable

Chengdu

2026-01-28

Recruiting

A Prospective, Multicenter, Randomized Controlled Clinical Trial of Transcatheter Tricuspid Valve Clipping Systems.

NCT07433504Severe or Greater Tricuspid Regurgitation

Shanghai Huihe Medical Technology Co., Ltd

Not applicable

132

Shanghai

2026-01-28

Recruiting

RWS of Tunlametinib in NRAS-Mutant Advanced Melanoma

NCT07445022Melanoma Advanced

DrugTunlametinib

Fudan University

Phase 4

110

Shanghai

2026-01-28

Recruiting

A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC

NCT07434518Small Cell Lung Cancer (SCLC)

DrugAdebrelimab

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Observational

500

Shanghai

2026-01-27

Recruiting

Effect of Intrauterine Insemination on Subsequent Pregnancy Outcomes in Couples With Unexplained Pregnancy Loss: A Multicenter, Open-label, Randomized Controlled Trial

NCT07759609Unexplained Pregnancy Loss

Lanzhou University Second Hospital

Not applicable

706

Beijing, Lanzhou, Shijiazhuang

2026-01-27

Recruiting

Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus

NCT07258394Type 1 Diabetes

DrugDimethyl Fumarate Enteric

Nanjing Medical University

Phase 3

Nanjing

2026-01-27

Recruiting

A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer

NCT07281976Triple Negative Breast Cancer

DrugsLBL-024·Albumin-Bound Paclitaxel·Toripalimab

Nanjing Leads Biolabs Co.,Ltd

Phase 1/2

220

Guangzhou, Harbin, Zhengzhou, Nanjing, Changchun, Shenyang

2026-01-27

Not yet open

Preventing Neurologic Complications in Valve Surgery

NCT07382362Left Atrial Appendage Closure

China National Center for Cardiovascular Diseases

Observational

100

Beijing, Qingdao, Shenzhen

2026-01-27

Not yet open

Efficacy and Safety of Qibei Jiedu Formula for Preventing and Managing Acute Radiation Dermatitis in Breast Cancer Patients

NCT07380230Acute Radiation Dermatitis, Traditional Chinese Medicine (TCM), Breast Cancer

LI FENG

Not applicable

Beijing

2026-01-27

Active, closed

Time-Restricted Eating for Weight-Loss Maintenance

NCT07163455Overweight or Obese Adults

Harbin Medical University

Not applicable

500

Beijing, Chongqing, Shenzhen, Harbin, Xi'an, Qingdao, Weifang, Chengdu

2026-01-26

Active, closed

A Study of Zasocitinib in Adults With Hidradenitis Suppurativa

NCT07244263Hidradenitis Suppurativa

DrugZasocitinib

Takeda

Phase 2

Beijing, Guangzhou, Wuhan, Shanghai, Hangzhou

2026-01-26

Recruiting

Evaluate the Safety, Tolerability, PK, and PD of JMT206 Injection in Healthy Participants

NCT07419698Healthy Participants

DrugJMT206

Shanghai JMT-Bio Inc.

Phase 1

Beijing

2026-01-26

Recruiting

Study of Ultra-Fast BCMA/CD70 CAR-T Therapy for Refractory SLE

NCT07318259Systemic Lupus Erythematosus

Chongqing Precision Biotech Co., Ltd

Phase 1

Nanjing

2026-01-26

Recruiting

Phase II Trial of PRT-064040 Nasal Spray for the Treatment of Migraine in Adults

NCT07304518Migraine

Sichuan Purity Pharmaceutical Technology Co., Ltd.

Phase 2

456

Beijing

2026-01-26

Recruiting

CS-121 APOC3 Base Editing in Children and Adolescents With Hyperchylomicronemia

NCT07371767Hyperchylomicronemia

DrugCS-121

Shanghai Jiao Tong University School of Medicine

Early Phase 1

Shanghai

2026-01-26

Recruiting

Lenvatinib Plus Chemotherapy for pNET Liver Metastases

NCT07835893Pancreatic Neuroendocrine Tumor With Liver Metastases

DrugLenvatinib

Peking Union Medical College Hospital

Phase 2

Beijing

2026-01-26

Active, closed

Effects of a Topical Serum Solution on Hair Characteristics

NCT07785869Hair Characteristics

DrugMinoxidil

Pacagen, Inc.

Not applicable

190

Guangzhou

2026-01-26

Not yet open

Repeated Low-Level Red-Light Therapy in Dry Age-Related Macular Degeneration

NCT07409389AMD - Age-Related Macular Degeneration

The Hong Kong Polytechnic University

Not applicable

Hong Kong

2026-01-26

Recruiting

Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled Trial

NCT07402525Oral Tongue Squamous Cell Carcinoma

Second Affiliated Hospital, Zhejiang University, School of Medicine

Not applicable

190

Bengbu, Chaoyang, Fuzhou, Guandong, Harbin, Wuhan, Changsha, Nanchang

2026-01-26

Active, closed

Objective Response Rate of Ivonescimab With Chemotherapy in Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinoma

NCT07686575HNSCC, OSCC, OPSCC, Ivonescimab

Zhujiang Hospital

Observational

Guangzhou

2026-01-26

Not yet open

A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Unresectable Hepatocellular Carcinoma

NCT07368023Hepatocellular Carcinoma, Hepatocellular Carcinoma Non-resectable

Ningbo Medical Center Lihuili Hospital

Observational

300

Ningbo

2026-01-25

Recruiting

Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification

NCT07319429Endometrial Cancer, Fertility

DrugsMedroxyprogesterone Acetate·Megestrol Acetate·Sintilimab

Fudan University

Phase 2/3

260

Shanghai

2026-01-25

Recruiting

Impact of Pre-Hospital Heparin Loading in STEMI Patients for Primary PCI: The HELP-PCI-2 Trial

NCT07361783Primary PCI, ST-elevation Myocardial Infarction (STEMI)

Chen Jing

Not applicable

6,294

Wuhan

2026-01-25

Not yet open

The Correlation and Mechanistic Study of GGCX Gene With Prognosis in Acute Ischemic Stroke

NCT07269288Acute Ischemic Stroke

Peking University Aerospace Center Hospital

Observational

1,500

Beijing

2026-01-25

Recruiting

Study of Predicting Lymph Node Metastasis of High-risk Prostate Cancer by Artificial Intelligence Multi-omics Analysis

NCT07112599Prostate Cancer, Lymph Node Cancer Metastatic, Artificial Intelligence (AI)

Anhui Medical University

Observational

2,000

Hefei

2026-01-25

Recruiting

Rehabilitation Exercise Against Complications in High-risk Elderly After Lumbar Fusion(REACH)

NCT07396051Adjacent Segment Degeneration, Multimodal Rehabilitation, Lumber Fusion

Xuanwu Hospital, Beijing

Not applicable

212

Beijing

2026-01-25

Recruiting

Predictive Value of Gastrointestinal Blood Flow for Enteral Nutrition Intolerance in Critically Ill Patients

NCT07521111Critical Illness, Enteral Nutrition Intolerance, Enteral Nutrition Feeding, Prediction Models

Ruijin Hospital

Observational

500

Shanghai

2026-01-25

Recruiting

Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AML

NCT07259707Acute Myeloid Leukemia, FLT3 Internal Tandem Duplication Positive, Intermediate Risk Acute Myeloid Leukemia, Fit Patients

First Affiliated Hospital of Zhejiang University

Phase 2

Hangzhou

2026-01-25

Recruiting

Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia

NCT07370519Androgenetic Alopecia (AGA)

DrugMinoxidil

Shenzhen People's Hospital

Phase 2

388

Shenzhen

2026-01-25

Recruiting

A Multicenter, Randomized, Open-label, Parallel-group, Controlled, Superiority Phase III Clinical Study Comparing the Efficacy and Safety of F182112 Versus Standard of Care in Patients With Relapsed or Refractory Multiple Myeloma

NCT07579234Relapsed or Refractory Multiple Myeloma (RRMM)

DrugsF182112 single-agent·Selinexor·Pomalidomide·Bortezomib

Shandong New Time Pharmaceutical Co., LTD

Phase 3

261

Tianjing

2026-01-25

Recruiting

Mechanisms and Interventions of Social Reward on Cognitive Control in Internet Gaming Disorder

NCT06957392Internet Gaming Disorder

The First Affiliated Hospital of Bengbu Medical University

Not applicable

Bengbu

2026-01-25

Recruiting

A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders

NCT07417813Insomnia, Psychiatric Disorders

DrugLemborexant

Shanghai Mental Health Center

Observational

121

Suzhou, Xuzhou, Shanghai, Hangzhou, Ningbo

2026-01-24

Active, closed

SERS-Based Diagnosis of Leptomeningeal Metastasis in EGFR-Mutant NSCLC

NCT07912723Lung Adenocarcinoma EGFR-mutated, Leptomeningeal Metastasis From Lung Cancer

limeifang

Observational

Fuzhou

2026-01-24

Not yet open

LLL vs. SDL for LBBP: A Non-inferiority RCT

NCT07378124Bradycardia, Conduction Block, Atrioventricular

Ningbo No.2 Hospital

Not applicable

288

Ningbo

2026-01-24

Recruiting

Oxytocin's Effects on Emotional Processing and Its Acting Routes

NCT07425938Healthy Adult Male

DrugOxytocin

University of Electronic Science and Technology of China

Not applicable

120

Chengdu

2026-01-24

By invitation

Vaginal Function Exercisers and Vaginal Dilation Irrigation Drug Administration Tubes Are Used for Vaginal Rehabilitation Therapy in Pelvic Radiotherapy

NCT07473271Indicated for Pelvic Radiotherapy, Vaginal Rehabilitation, and Alleviation of Late Toxic Reactions in the Vagina

Peking Union Medical College Hospital

Not applicable

Beijing

2026-01-23

Recruiting

A Phase III Study of CM326 in Subjects With Moderate to Severe Asthma

NCT07372287Moderate to Severe Asthma

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Phase 3

230

Shanghai

2026-01-23

Recruiting

Research and Clinical Validation of a Wearable Device-Based Remote Rehabilitation System for Postoperative Rotator Cuff Injury

NCT07412184Rotator Cuff Tear

Peking University Third Hospital

Not applicable

Beijing

2026-01-23

Recruiting

Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

NCT07230288Idiopathic Pulmonary Fibrosis

AbbVie

Phase 2

165

2026-01-23

Recruiting

Effects of Enteral Feeding Regimens on NEC, Mortality, and Neurodevelopment in Very Preterm Infants

NCT07045844Very Preterm Infant, Necrotizing Enterocolitis (NEC)

The Children's Hospital of Zhejiang University School of Medicine

Not applicable

2,324

Guilin, Yulin, Zhengzhou, Wuhan, Yiyang, Hohhot, Ganzhou, Yinchuan

2026-01-23

Active, closed

Toripalimab Plus Bevacizumab Combined Three Intra-arterial Therapies (TACE, HAIC, or TACE-HAIC) for Unresectable Hepatocellular Carcinoma: a Phase 2, Multicenter Randomised Non-comparative Trial

NCT07380633Hepatocellular Carcinoma (HCC)

DrugsTACE·HAIC

Sun Yat-sen University

Phase 2

Guangzhou

2026-01-23

Recruiting

A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer

NCT07309276Advanced Lung Cancer

DrugsJS213·JS212·JS207·Toripalimab

Shanghai Junshi Bioscience Co., Ltd.

Phase 2

864

Shanghai

2026-01-23

Recruiting

A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABP

NCT07327619Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia

DrugsMeropenem and Pralurbactam·Ceftazidime-avibactam

Qilu Pharmaceutical Co., Ltd.

Phase 3

420

Huaihua

2026-01-22

Recruiting

A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3122 Capsules in Subjects With Advanced Malignant Tumors

NCT07269145Advanced Cancer

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1

Beijing, Fuzhou, Meizhou, Shanghai, Chengdu

2026-01-22

Recruiting

Evaluate the Use of [18F]-APN-1607 PET in Subjects With AD-related Cognitive Impairment and Subjects With Normal Cognitive Function

NCT07422857Subjects With Mild Cognitive Impairment (MCI) of AD, Alzheimer's Disease (AD) Dementia

Drug[18F]-APN-1607

JYAMS PET Research & Development Limited

Phase 3

316

Wuhan, Shanghai

2026-01-22

Not yet open

Standardization and Application of Pure Platelet-Rich Plasma in Improving Sperm Function

NCT07348354Infertility

Chinese University of Hong Kong

Not applicable

248

Hong Kong

2026-01-22

Recruiting

A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases

NCT07413341Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome (SS), Systemic Sclerosis (SSc), Inflammatory Myopathy

Therorna

Phase 1

Shanghai

2026-01-22

Recruiting

Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion Stroke

NCT07357987Ischemic Stroke, Medium Vessel Occlusion, Tenecteplase, Endovascular Treatment

Beijing Tiantan Hospital

Phase 3

488

Beijing

2026-01-22

Active, closed

Safety, Tolerability, and Pharmacokinetics of Multiple-Dose RFUS-949 in Healthy Chinese Participants

NCT07676357Acute and Chronic Pain

The Affiliated Hospital of Qingdao University

Phase 1

Qingdao

2026-01-22

Recruiting

Efficacy and Safety of Anrikefon for Postoperative Analgesia in Ophthalmic Surgery

NCT07269106Ophthalmic Surgery, Postoperative Pain Management, Opioid Analgesia

DrugsAnrikefon·Nalbuphine

Zhongshan Ophthalmic Center, Sun Yat-sen University

Phase 4

204

Guangzhou, Kunming, Shanghai

2026-01-22

Recruiting

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

NCT07277231Chronic Lymphocytic Leukemia

DrugsSonrotoclax·Acalabrutinib·Venclexta·Zanubrutinib

BeOne Medicines

Phase 3

500

Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Guiyang, Harbin, Zhengzhou

2026-01-22

Recruiting

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

NCT07184944Crohn's Disease

DrugDuvakitug

Sanofi

Phase 3

751

Guangzhou, Huizhou, Shanghai, Wuxi

2026-01-22

Recruiting

G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell Transplantation

NCT07362810Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB), Hematopoetic Stem Cell Transplantation, Hemato-oncologic Patients

DrugG-Csf

Fudan University

Phase 2

224

Fuzhou, Zhengzhou, Nanchang, Shanghai, Hangzhou

2026-01-22

Recruiting

Extension Study of the Phase 3 Clinical Study of GZR18 Injection for Weight Loss

NCT07292441Overweight or Obesity

DrugBofanglutide

Gan & Lee Pharmaceuticals.

Phase 3

500

Beijing

2026-01-22

Recruiting

Efficacy and Safety of Fully Resorbable Sinus Drug-eluting Stents in Patients With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps After Surgery: A Prospective, Randomized Controlled Trial

NCT07498374Eosinophilic Chronic Rhinosinusitis With Nasal Polyps

Tang-Du Hospital

Not applicable

192

Xi'an

2026-01-21

Recruiting

Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study

NCT07581834Breast Diseases, Breast Neoplasms, Dalpiciclib, Endocrine Breast Diseases

DrugDalpiciclib

Fujian Cancer Hospital

Phase 2

2,000

Fuzhou, Chengdu

2026-01-21

Recruiting

Combination of Rituximab and Cyclosporine in the Treatment of Primary Membranous Nephropathy

NCT07861204Membranous Nephropathy

DrugsCyclosporine·Rituximab

Peking University First Hospital

Phase 2/3

Beijing

2026-01-21

Not yet open

Phase Ib/II Study of QL1706 + Fruquintinib + SCRT vs. Standard Third-Line Therapy in Unresectable Liver-Metastatic pMMR/MSS Colorectal Cancer: Safety, Tolerability, and Efficacy.

NCT07353268Colorectal Cancer

DrugsFruquintinib·Lenvatinib

Tao Zhang

Phase 2

Wuhan

2026-01-21

Recruiting

A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer

NCT07347600Locally Advanced Breast Cancer, Metastatic Breast Cancer

DrugsInavolisib·Palbociclib·Fulvestrant

Hoffmann-La Roche

Observational

500

Xiamen, Lanzhou, Shijiazhuang, Changchun, Wenzhou, Beijing, Chengdu, Chongqing

2026-01-21

Recruiting

Remimazolam for Reducing Postoperative Delirium in Elderly Patients Undergoing Laparoscopic Gastrectomy

NCT07351474Gastric Cancer, Postoperative Delirium

DrugsRemimazolam·Propofol

The First Affiliated Hospital with Nanjing Medical University

Not applicable

170

Nanjing

2026-01-21

Recruiting

A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)

NCT07229625Advanced Biliary Tract Cancer

DrugsSHR-8068·Adebrelimab·Durvalumab·Gemcitabine

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Phase 3

604

Hangzhou

2026-01-21

Recruiting

Multicenter Prospective Non-randomized Controlled Study of ALA-PDT for LSIL With HPV16/18 Infection

NCT07306247HPV-16/18, Photodynamic Therapy (PDT), LSIL, Low Grade Squamous Intraepithelial Lesion

Second Affiliated Hospital, Zhejiang University, School of Medicine

Not applicable

225

Hangzhou, Ningbo, Shaoxing

2026-01-21

Recruiting

A Phase I Study to Evaluate the Safety and Preliminary Efficacy of [225Ac]Ac-DOTATATE Injection Combined With Tislelizumab in the Maintenance Treatment Period for Patients of Extensive-stage Small Cell Lung Cancer (ES-SCLC) With Somatostatin Receptors (SSTR)+ as First-line Treatment

NCT07413042SCLC, Extensive Stage

Drug[225Ac]Ac-DOTATATE

Peking University Cancer Hospital & Institute

Phase 1

Beijing

2026-01-20

Recruiting

Efficacy and Safety of Ivonescimab Monotherapy as First-Line Treatment for PD-L1-Positive, Driver Gene-Negative, Locally Advanced or Metastatic NSCLC: A Multicenter, Prospective, Real-World Cohort Study

NCT07696832Patients Must Have Histologically or Cytologically Confirmed Locally Advanced or Metastatic NSCLC, EGFR Mutation-negative and ALK Rearrangement-negative, Eastern Cooperative Oncology Group Performance Status (ECOG PS) Score of 0 to 2, No Prior Systemic Therapy Received for the Advanced or Metastatic Disease

DrugIvonescimab

Guangdong Association of Clinical Trials

Observational

265

Guangzhou

2026-01-20

Recruiting

Epirubicin Interventional Chemotherapy for Sinonasal Adenoid Cystic Carcinoma (SNACC): A Prospective Study

NCT07320508Adenoid Cystic Carcinoma, Sinonasal Carcinoma, Epirubicin

DrugEpirubicin

Eye & ENT Hospital of Fudan University

Phase 2

100

Shanghai

2026-01-20

Recruiting

A Single-Arm Phase Ⅱ Study of Fluzoparib Maintenance in Platinum-sensitive Advanced Triple-Negative Breast Cance

NCT07321015Platinum-sensitive, TNBC, Triple Negative Breast Cancer, BRCA1/2 Mutation or Not

DrugFluzoparib

Tianjin Medical University Cancer Institute and Hospital

Phase 2

Tianjin

2026-01-20

Recruiting

Enteral Nutrition Delivery in Prone Position Ventilated Patients With Moderate to Severe ARDS

NCT07362537ARDS

Southeast University, China

Not applicable

Nanjing

2026-01-20

Recruiting

T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-CR

NCT07353840Peripheral T Cell Lymphoma

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Observational

160

Shanghai

2026-01-20

Not yet open

NK-cell Therapy Combined With PD-1 Antibody and Platinum-Based Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC

NCT07318636Resectable Non-small Cell Lung Cancer

The First Affiliated Hospital of Guangzhou Medical University

Phase 1

Guangzhou

2026-01-20

By invitation

Use of cfDNA in Monitoring and Guiding Treatment for Cervical Cancer

NCT07919431Cervical Cancer Screening

Peking Union Medical College Hospital

Observational

100

Beijing

2026-01-20

Recruiting

Treatment Outcomes for Portal Hypertension Esophageal and Gastric Varices

NCT07358663Esophagogastric Varices, Portal Hypertension

Shanghai Zhongshan Hospital

Observational

1,384

Shanghai

2026-01-20

Recruiting

A Single-Center, Open-Label, Single Ascending Dose Study of Exenatide Circular RNA-Lipid Nanoparticle Injection (CR059) in Chinese Subjects With Type 2 Diabetes Mellitus

NCT07347080T2DM

The First Affiliated Hospital of Henan University of Science and Technology

Early Phase 1

Luoyang

2026-01-20

Recruiting

The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born Small for Gestational Age

NCT07309562Small for Gestational Age

DrugsInpegsomatropin·Recombinant Human Growth Hormone

Xiamen Amoytop Biotech Co., Ltd.

Phase 3

141

Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Haikou

2026-01-20

Recruiting

Clinical Efficacy and Health Economic Evaluation of an Intelligent Diagnostic and Treatment Model

NCT07357779Insomnia

Zan Wang

Not applicable

404

Changchun

2026-01-20

Recruiting

Tenecteplase Plus Urinary Kallidinogenase for Acute Ischemic Stroke (TUKIS)

NCT07283159Ischemic Stroke

DrugHuman Urinary Kallidinogenase

General Hospital of Shenyang Military Region

Phase 2

200

Shenyang

2026-01-20

Recruiting

A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors

NCT07263594Gastrointestinal Cancer

DualityBio Inc.

Phase 1/2

127

Beijing

2026-01-20

Recruiting

A Study on the Effect of Medical Students' Literature Reading Patterns on Cognitive Load and Academic Writing Ability

NCT07460258Accuracy in Understanding the Core Content of English Medical Literature

Zhongnan Hospital

Observational

160

Wuhan

2026-01-20

Recruiting

A Multicenter Prospective Study on the Performance of Spectral CT for Evaluating Treatment Response After TACE in Hepatocellular Carcinoma

NCT07351669HCC - Hepatocellular Carcinoma, TACE(Transcatheter Arterial Chemoembolization), CT

Zhongda Hospital

Observational

121

Nanjing

2026-01-20

Not yet open

Brain Stimulation for Postherpetic Neuralgia: A Randomized Sham-Controlled Trial

NCT07352553Postherpetic Neuralgia

Huazhong University of Science and Technology

Not applicable

Wuhan

2026-01-20

Not yet open

A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

NCT07313917Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

DrugLP-003

Longbio Pharma

Phase 2

150

Beijing

2026-01-20

Recruiting

JY232(JY232) Injection in Relapsed/Refractory Multiple Myeloma

NCT07336823Multiple Myeloma

Shenzhen Genocury Biotech Co., Ltd.

Early Phase 1

Foshan

2026-01-20

Active, closed

A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis

NCT07230860Dermatitis, Atopic

DrugJNJ-95597528

Janssen Research & Development, LLC

Phase 2

189

Beijing, Changsha, Chengde, Chengdu, Guangzhou, Sanmenxia, Wuxi, Xi'an

2026-01-20

Not yet open

Safety and Efficacy of FAP iCDC in Acute Myocardial Infarction With Cardiogenic Shock

NCT07380659Cardiogenic Shock, Cardiogenic Shock Post Myocardial Infarction, STEMI - ST Elevation Myocardial Infarction

Second Affiliated Hospital, Zhejiang University, School of Medicine

Phase 1

Hangzhou

2026-01-20

Not yet open

Research on the Extraction of Tongue and Facial Diagnosis Features of Psoriasis Vulgaris in Traditional Chinese Medicine and Its Correlation With Laboratory Indicators

NCT07351448Psoriasis (PsO), Traditional Chinese Medicine (TCM), Diagnosis

Shanghai Yueyang Integrated Medicine Hospital

Observational

450

Shanghai

2026-01-20

By invitation

A Study on the Efficacy and Safety of Endoscopic Ultrasound-guided Gastro-/Duodeno-cholecystostomy for the Treatment of Gallstones.

NCT07522385Gall Stones, Gall Stones (& [Calculus - Gall Bladder])

Tongji Hospital

Not applicable

Wuhan

2026-01-20

Recruiting

A Phase II Study to Evaluate the Efficacy and Safety of HLX43 + Serplulimab as Neoadjuvant Therapy in Subjects With NSCLC

NCT07269782Non Small Cell Lung Cancer

DrugsHLX43 2·HLX43 1·Serplulimab

Shanghai Henlius Biotech

Phase 2

Shanghai

2026-01-20

Recruiting

A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer

NCT07339267Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer

DrugsPRL-02·Prednisone

Astellas Pharma Global Development, Inc.

Phase 1

Beijing

2026-01-20

Recruiting

A Multicohort Study of Toripalimab in Combination With Investigator-Selected Chemotherapy for Advanced HER2-Negative Breast Cancer

NCT07540533Advanced Breast Cancer

DrugToripalimab

Henan Cancer Hospital

Phase 2

Zhengzhou

2026-01-20

Recruiting

Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

NCT07297563Immune Thrombocytopenia, Treatment

DrugsDaratumumab·Rituximab

Institute of Hematology & Blood Diseases Hospital, China

Phase 2

160

Tianjin

2026-01-20

Not yet open

Nevus Removal vs. Conservative Treatment in Halo Nevus With Vitiligo: A Randomized Study

NCT07307534Vitiligo, Halo Nevus

Xijing Hospital

Not applicable

Xi'an

2026-01-20

Active, closed

Multimodal Neurofunctional Profiling in Stroke

NCT07411573Stroke

Peking Union Medical College Hospital

Observational

1,000

Beijing

2026-01-20

Recruiting

Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours

NCT07203625Acute Ischemic Stroke, Basilar Artery Occlusion

DrugRhTNK-tPA

Xuanwu Hospital, Beijing

Phase 4

316

Beijing

2026-01-20

Recruiting

Impact of Serum Progesterone Levels on Embryo Transfer Day on Clinical Pregnancy

NCT07388797Reproductive Issues

Chinese University of Hong Kong

Observational

370

Hong Kong

2026-01-20

Recruiting

A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset.

NCT07520565AIS

Biocells (Beijing) Biotech Co.,Ltd

Phase 3

1,112

Hengshui, Daqing, Nanyang, Meihekou, Shenyang, Xianyang, Linyi, Linfen

2026-01-19

Recruiting

Evaluating the Efficacy and Short-Term Prognosis of Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis(AS): A Protocol for a Cohort Study

NCT07556224Ankylosing Spondylitis (AS)

China-Japan Friendship Hospital

Observational

790

Beijing

2026-01-19

Recruiting

Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis (AS): A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System

NCT07509775Ankylosing Spondylitis (AS)

China-Japan Friendship Hospital

Observational

210

Beijing

2026-01-19

Recruiting

Inspiratory Effort-Targeted Pressure Support Ventilation (IT-PSV) Trial

NCT06526598Critical Care, Acute Hypoxic Respiratory Failure, Ventilator-Induced Lung Injury

Capital Medical University

Not applicable

619

Beijing

2026-01-19

Recruiting

A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma

NCT07328009Hepato Cellular Carcinoma (HCC)

DrugsTudca·HAIC·Xelox·Regorafenib

Fudan University

Phase 2

350

Shanghai

2026-01-19

Recruiting

A Study of HB0017 Injection in Healthy Volunteers to Evaluate Safety and Tolerability of a Single Subcutaneous Injection in Low-Body-Weight Subjects; and Pharmacokinetics at Different Subcutaneous Injection Sites at the Same Dose

NCT07920861Psoriasis, Ankylosing Spondylitis

Huabo Biopharm Co., Ltd.

Phase 1

Hangzhou

2026-01-19

Recruiting

First in Human Study of SIM0610 in Solid Tumors

NCT07348211Advanced Solid Tumours, Non-Small Cell Lung Cancer, Colorectal Cancer, Head and Neck Squamous Cell Carcinoma

Jiangsu Simcere Pharmaceutical Co., Ltd.

Phase 1

260

Chongqing, Harbin, Shenyang, Jinan, Shanghai

2026-01-19

Active, closed

A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis

NCT07233655Moderate to Severe Active Rheumatoid Arthritis

Guangdong Hengrui Pharmaceutical Co., Ltd

Phase 2

Beijing

2026-01-19

Recruiting

A Phase II Study of SKB571 in Patients With Lung Cancer

NCT07230405Lung Cancer (Non-Small Cell)

DrugSKB571

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Phase 2

295

Guangzhou, Zhengzhou

2026-01-19

Recruiting

Study to Assess the Efficacy and Safety of QHRD106 Injection in Acute Ischemic Stroke.

NCT07396337Acute Ischemic Stroke

Changzhou Qianhong Bio-pharma Co., Ltd.

Phase 2

320

Nanjing

2026-01-19

Recruiting

Laparoscopic Versus Open Surgery for Colon Cancer With Visceral Obesity

NCT07314996Colonic Neoplasms

Second Affiliated Hospital, Zhejiang University, School of Medicine

Not applicable

664

Hangzhou

2026-01-18

Recruiting

A Study (Phase 1b/2) of GS3-007a Oral Treatment in Children With Growth Hormone Deficiency (PGHD)

NCT07264595Pediatric Growth Hormone Deficiency

DrugRhGH

Changchun GeneScience Pharmaceutical Co., Ltd.

Phase 1/2

Wuhan

2026-01-18

Recruiting

Bacillus Subtilis and Enterococcus Faecium Probiotic Plus Lipid-Lowering Therapy for Hypertriglyceridemic Acute Pancreatitis: A Prospective RCT

NCT07720232Hypertriglyceridemic Acute Pancreatitis, Acute Pancreatitis, Hypertriglyceridemia-induced, Hyperlipidemia

Jianyin Zhou

Phase 4

180

Xiamen

2026-01-18

Recruiting

The Effects of Transcranial Current Stimulation on Insomnia

NCT07340268Insomnia, Psychophysiological

Zan Wang

Not applicable

100

Ch’ang-ch’un

2026-01-18

Not yet open

Effect of Esketamine on Perioperative Negative Emotions in Patients Undergoing Breast Cancer Surgery

NCT07367542Depression, Anxiety, S-ketamine, Breast Cancer

DrugEsketamine

Chinese PLA General Hospital

Not applicable

218

Beijing

2026-01-17

Recruiting

Cardiac Safety Management and Immune Microenvironment Changes After Thoracic Radiotherapy: A Prospective Observational Study

NCT07669493MACE, Arrhythmia, Pericardial Effusion and Survival

Hebei Medical University Fourth Hospital

Observational

150

Shijiazhuang

2026-01-17

Recruiting

The Effects of Anesthesia Type on the Prognosis of Hip Fracture Surgery on Elderly Patients

NCT03116490Postoperative Complications, Postoperative Mortality

Wenzhou Medical University

Observational

600

Wenzhou

2026-01-16

Recruiting

Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease

NCT07694674Inflamatory Bowel Disease, Crohn Disease (CD)

DrugsUstekinumab·Vedolizumab·Infliximab·Adalimumab

Shanghai 10th People's Hospital

Observational

198

Shanghai

2026-01-16

Recruiting

Fruquintinib Plus Anti-EGFR Antibody for Third-Line Treatment of RAS Wild-Type mCRC

NCT07724223Metastatic Colorectal Cancer (CRC)

DrugFruquintinib

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2

Beijing

2026-01-16

Not yet open

Efficacy and Safety of Coenzyme I for Injection on Vascular Aging.

NCT07328100Vascular Aging, NAD

DrugCoenzyme I

Shanghai 10th People's Hospital

Not applicable

Shanghai

2026-01-16

Active, closed

Study to Evaluate the Preliminary Efficacy of SKB264 and the Effect of Clarithromycin on the PK of SKB264 in OC

NCT07341100Ovarian Epithelial Cancer

DrugsClarithromycin·Sacituzumab tirumotecan

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Phase 2

Guangdong

2026-01-16

Recruiting

A Study of MHB048C in Patients With Advanced Solid Tumors

NCT07192120mCRPC (Metastatic Castration-resistant Prostate Cancer), Advanced Malignant Solid Tumor

Minghui Pharmaceutical (Hangzhou) Ltd

Phase 1/2

200

Shanghai

2026-01-16

Recruiting

A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic Arthritis

NCT07315061PsA (Psoriatic Arthritis)

DrugD-2570

InventisBio Co., Ltd

Phase 2

222

Chengdu

2026-01-16

Recruiting

Effect of Titrated Administration of Ciprofol on Perioperative Hypotension in Elderly Patients Undergoing Laparoscopic Abdominal Surgery: A Randomized Controlled Trial

NCT07328958Hypotension During Surgery

Sixth Affiliated Hospital, Sun Yat-sen University

Not applicable

500

Guangzhou

2026-01-16

Recruiting

TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients

NCT07480785Uterine Fibroids (Leiomyoma), Ovarian Tumors, Gallstones

Zhejiang University

Not applicable

780

Hangzhou

2026-01-16

Recruiting

Phase Ib/II Clinical Study of QLS1304 Combined With Endocrine Therapy in the Treatment of ER+/HER2- Breast Cancer Patients

NCT07235176Advanced ER+/HER2- Breast Cancer

DrugsQLS1304·CDK4/6i·Fulvestrant/AI·Fulvestrant

Qilu Pharmaceutical Co., Ltd.

Phase 1/2

300

Shanghai

2026-01-16

Recruiting

Safety, Efficacy and Cellular Metabolic Dynamics of CT1195E in Patients With Refractory / Progressive SSC

NCT07355972SSc-Systemic Sclerosis

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Early Phase 1

Wuhan

2026-01-16

Recruiting

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

NCT07195695Non-small Cell Lung Cancer

DrugsZongertinib·Atezolizumab·Durvalumab·Nivolumab

Boehringer Ingelheim

Phase 3

400

Beijing, Changchun, Changsha, Chengdu, Guangzhou, Hangzhou, Harbin, Jinan

2026-01-16

Recruiting

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

NCT07185009Ulcerative Colitis

DrugDuvakitug

Sanofi

Phase 3

751

Guangzhou, Huizhou, Wuxi, Chengdu, Beijing, Hefei, Kunming, Shanghai

2026-01-16

Recruiting

Real-time Neurofeedback Training of the Medial Prefrontal Cortex Based on Imagined Social Support

NCT07364084Healthy, Neurofeedback

University of Electronic Science and Technology of China

Not applicable

Chengdu

2026-01-16

Active, closed

A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)

NCT07230119Overweight , Obesity

DrugZovaglutide

Beijing QL Biopharmaceutical Co.,Ltd

Phase 3

755

Xuancheng, Beijing, Chongqing, Lanzhou, Guangzhou, Huizhou, Nanning, Handan

2026-01-16

By invitation

China-NINE Cohort：Neuroimmune Network in Elderly / Neurodegeneration

NCT07586501Cognitive Dysfunction, Cognitive Dysfunction, Cognitive Disorder, Parkinson's Disease (PD)

Yantai Yuhuangding Hospital

Observational

260

Yantai

2026-01-16

Recruiting

A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus Erythematosus

NCT07339332Systemic Lupus Erythematosus (SLE)

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Early Phase 1

Wuhan

2026-01-16

Recruiting

A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease

NCT07493603Coronary Heart Disease, Coronary Artery Disease, Atheroscleroses

Xia Liang

Phase 1/2

Huzhou

2026-01-16

Recruiting

Mapping of the Developmental Atlas of the Visual System and Research on Embryonic Neurogenesis Phenomena

NCT07688538Embryonic Development, Retinal Anomalies, Neural Development

Sheng Liu

Observational

200

Guangzhou

2026-01-16

Not yet open

Effect of Intranasal Negative Pressure Therapy on Cognitive Function in Patients With Mild Cognitive Impairment and Obstructive Sleep Apnea

NCT07353359Mild Cognitive Impairment (MCI)

Xuanwu Hospital, Beijing

Not applicable

Beijing

2026-01-15

Not yet open

Modified Shenling Baizhu Powder for Allergic Asthma With Spleen Deficiency and Dampness Accumulation Syndrome

NCT07352488Allergic Asthma

Henan University of Traditional Chinese Medicine

Not applicable

400

Zhengzhou, Jinan, Hangzhou

2026-01-15

Not yet open

Evaluation of the Diagnostic Efficacy of a αvβ6/FAP-Targeting Heterodimeric Probe in Patients With Malignant Solid Tumors

NCT07385950PET / CT, Solid Tumors, Adult

Zhongnan Hospital

Observational

100

Wuhan

2026-01-15

Recruiting

Efficacy and Safety of Rifaximin-α in Treating MASLD

NCT07381257Metabolic Dysfunction-Associated Steatotic Liver Disease

DrugRifaximin

Shanghai Changzheng Hospital

Early Phase 1

Shanghai

2026-01-15

Recruiting

A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma

NCT07297212Recurrent Glioblastoma

DrugsPumitamig·Temozolomide·Bevacizumab

BioNTech SE

Phase 2

Beijing, Chongqing, Jinan, Shanghai, Shenzhen, Wuhan

2026-01-15

Recruiting

Electro-Acupuncture in Lung cancER : EALER Study

NCT07337096Non Small Cell Lung Cancer, Accupuncture, PD-1 Inhibitors

Guangzhou University of Traditional Chinese Medicine

Not applicable

424

Guangzhou, Nanjing

2026-01-15

Not yet open

DragonFly M2 Pivotal Study

NCT07243197Mitral Valve (MV) Regurgitation

Hangzhou Valgen Medtech Co., Ltd

Not applicable

Shenzhen

2026-01-15

Not yet open

Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First-Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer

NCT07360132Squamous Non-small Cell Lung Cancer

DrugsPaclitaxel·Carboplatin

Shanghai Huaota Biopharmaceutical Co., Ltd.

Phase 3

480

Shanghai

2026-01-15

Not yet open

Huangjing Yangji Formula Combined With Resistance Training for Sarcopenia

NCT07321535Sarcopenia

Wangjing Hospital, China Academy of Chinese Medical Sciences

Not applicable

106

Beijing, Changsha, Tianjin

2026-01-15

Recruiting

Thrombolysis in Early Acute Ischemic Stroke Trial-Blood Pressure Management

NCT07279259Stroke, Acute Ischemic Stroke, Thrombolysis

Shanghai East Hospital

Phase 2

340

Shanghai

2026-01-15

Not yet open

Huaier Granule and Proteinuria

NCT07355361Proteinuria, Breast Cancer Patients

DrugHuaier

Fudan University

Phase 2

120

Shanghai

2026-01-15

Not yet open

Effects of a Specific Dietary Program on Overweight/Obese Women With Polycystic Ovary Syndrome: A Multicenter, Prospective, Randomized Controlled Clinical Study

NCT07350889Polycystic Ovary Syndrome (PCOS)

Xuanwu Hospital, Beijing

Not applicable

160

Beijing

2026-01-15

Active, closed

A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis

NCT07321873Arthritis, Psoriatic

Janssen Research & Development, LLC

Phase 2

157

Beijing, Changsha, Changzhou, Chengdu, Chongqing, Hangzhou, Ningbo, Shanghai

2026-01-15

Recruiting

A Study of DZD8586 in Adults With Primary Immune Thrombocytopenia (ITP) (TAI-SHAN11)

NCT07294365Immune Thrombocytopenia (ITP)

DrugBirelentinib

Dizal Pharmaceuticals

Phase 2

Jinan

2026-01-15

Recruiting

Multicenter Study to Evaluate the Effectiveness and Safety of Flow-Diverting Stents for Distal Intracranial Aneurysms

NCT07376590Aneurysms

First Affiliated Hospital of Zhejiang University

Observational

164

Hangzhou

2026-01-15

Recruiting

Postoperative Radiotherapy for Postoperative N2 Metastases of NSCLC in the Immunotherapy Era (Phase II)

NCT07320105Non-Small Cell Lung Cancer

DrugTislelizumab

Fujian Cancer Hospital

Phase 4

Fuzhou

2026-01-15

Not yet open

Enhanced Ward Rounds and Communication for Pre-procedural Anxiety in GI Endoscopy Patients

NCT07286877Anxiety, Depression Disorders, Sleep Wake Disorders, Gastrointestinal Diseases

LanZhou University

Not applicable

1,000

Lanzhou

2026-01-15

Recruiting

CD19 CAR-T Therapy for Refractory Pemphigus Vulgaris

NCT07681388Pemphigus Vulgaris

Jinbo Chen

Not applicable

Wuhan

2026-01-15

Not yet open

Efficacy and Safety of Microtransplantation for Advanced and Relapsed Solid Tumors

NCT07356856Advanced and Relapsed Solid Tumors

The Affiliated Hospital of the Chinese Academy of Military Medical Sciences

Phase 1

Haidian, Nanning

2026-01-15

Recruiting

Effect of Dexmedetomidine Combined With FNB/ACB on Sleep Quality After Knee Surgery

NCT07767383Knee Arthroscopic Surgery

DrugsRopivacaine·Dexmedetomidine

Affiliated Hospital of Nantong University

Phase 4

136

Nantong

2026-01-15

Not yet open

Clinical Study of XP-006 mRNA Vaccine for R/R B-NHL

NCT07334574B-cell Non-Hodgkin's Lymphoma (B-NHL)

DrugPersonalized neoantigen tumor vaccine

Ruijin Hospital

Phase 1

Shanghai

2026-01-15

Recruiting

Effect of Tegileridine Versus Sufentanil as Analgesic Components on Opioid-Induced Cough During Anesthesia Induction

NCT07323043General Anesthetic Drug Adverse Reaction

DrugSufentanil

The First People's Hospital of Lianyungang

Not applicable

190

Lianyungang

2026-01-15

Not yet open

Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Tislelizumab Combined With Chemotherapy as First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer

NCT07383116Non Squamous Non-small Cell Lung Cancer

DrugsHB0025·Pemetrexed·Tislelizumab·Cisplatin

Shanghai Huaota Biopharmaceutical Co., Ltd.

Phase 3

500

Shanghai

2026-01-15

Recruiting

Study on the Cosmetic Outcome and Safety Evaluation of 3D Printed Biodegradable Biological Mesh for One-Stage Breast Reconstruction After Radical Mastectomy

NCT07365267Breast Cancer, Breast Reconstruction After Mastectomy, 3D-Printed Biodegradable Biological Mesh

Xijing Hospital

Not applicable

Xi'an

2026-01-15

Recruiting

Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL

NCT07372352Peripheral T Cells Lymphoma (PTCL)

DrugsMitoxantrone Hydrochloride Liposome·Zeprumetostat·Azacitidine

The First Affiliated Hospital of Soochow University

Phase 2

Suzhou

2026-01-15

Not yet open

Phase Ib/IIa Clinical Trial of SIBP-A16 Injection in Premature Infants and Full-term Infants

NCT07363837Respiratory Syncytial Virus (RSV)

DrugsSIBP-A16·Nirsevimab

Shanghai Institute Of Biological Products

Phase 1/2

Chengdu

2026-01-15

Not yet open

Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

NCT07231250DLBCL - Diffuse Large B Cell Lymphoma, Chemo-free Therapy, Bispecific Antibody

DrugsPolatuzumab Vedotin·Lisaftoclax·Glofitamab·Doxorubicin

Li Zhiming

Phase 2

Guangzhou

2026-01-15

Recruiting

A Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2072 Tablets

NCT07647783Healthy Participants

DrugSYH2072

InnovStone Therapeutics Limited

Phase 1

112

Beijing

2026-01-15

Recruiting

A Quantitative, Cross-Sectional and Observational Study to Characterize Age-Related Structural Changes in Facial Skin of Chinese Women Using Line-Field Confocal Optical Coherence Tomography (LC-OCT)

NCT07415798Female, Facial Skin

ChinaNorm

Observational

100

Shanghai

2026-01-15

Not yet open

Propranolol Combined With Novel Endocrine Therapy and Androgen Deprivation Therapy (ADT) for Neoadjuvant Treatment in High-Risk Prostate Cancer Patients: A Multicenter, Single-Arm Clinical Study

NCT07311915Prostate Cancer

DrugPropranolol

Zhongda Hospital

Not applicable

Nanjing

2026-01-15

Recruiting

A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China

NCT07361289Hypertrophic Cardiomyopathy

DrugMavacamten

Bristol-Myers Squibb

Observational

500

Beijing, Guangzhou, Jiazhuang, Zhengzhou, Suzhou, Changchun, Dalian, Xi'an

2026-01-15

Recruiting

Sintilimab Plus Bevacizumab Biosimilar as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma

NCT07324824Hepatocellular Carcinoma, Neoadjuvant Therapy, Sintilimab, Bevacizimab

DrugsBevacizumab biosimilar·Sintilimab

Sun Yat-sen University

Phase 2

Guangzhou

2026-01-14

Recruiting

Prediction Model for MINS After Major Hepatobiliary Surgery

NCT07335042Myocardial Injury After Noncardiac Surgery (MINS), Postoperative Complications, Liver Neoplasm, Hepatobiliary Diseases

Beijing Tsinghua Chang Gung Hospital

Observational

1,800

Beijing, Chongqing, Qingdao, Shandong, Zhuhai

2026-01-14

Recruiting

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

NCT07325292Multiple Sclerosis

DrugsMRI contrast-enhancing preparations·Frexalimab

Sanofi

Phase 3

160

Beijing, Chengdu, Dongguan, Guangzhou, Jiazhuang, Shenyang

2026-01-14

Recruiting

A Phase 4 Study to Evaluate the Effectiveness and Safety of Siltartoxatug Injection for Tetanus Prophylaxis Following Injury

NCT07347938Tetanus

DrugSiltartoxatug

Zhuhai Trinomab Pharmaceutical Co., Ltd.

Observational

6,000

Hangzhou

2026-01-14

Active, closed

A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)

NCT07266090SLE - Systemic Lupus Erythematosus

DrugCenerimod

Viatris Pharmaceuticals Co., Ltd.

Phase 2

Guangzhou, Shijiazhuang, Luoyang, Zhengzhou, Jiujiang, Nanchang, Beijing

2026-01-14

Recruiting

Comparing Cleaning Tools for Full-Arch Implant-Supported Fixed Prostheses

NCT07474493Edentulism

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Not applicable

Shanghai

2026-01-14

Recruiting

Sintilimab Plus NALIRIFOX or Gemcitabine-Cisplatin as First-Line Treatment for Metastatic Biliary Tract Cancer

NCT07831993Biliary Tract Cancer

DrugsIrinotecan Hydrochloride Liposome·Fluorouracil·Leucovorin·Sintilimab

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 2

Nanjing

2026-01-14

Active, closed

Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate Hypertension

NCT07297797Mild to Moderate Hypertension

Fujian Shengdi Pharmaceutical Co., Ltd.

Phase 2

238

Beijing

2026-01-14

Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 7 November 2026. https://priyalifescience.com/clinical-trials-china?page=10

Query this register directly

GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 07 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in China?

11,790 of the 19,187 studies in this register are recruiting new participants as of the 07 Nov 2026, 03:17 UTC sync. A further 3,998 have not yet opened recruitment, 2,715 are active but closed to new participants, and 684 are enrolling by invitation only. Eligibility for any study is decided by its study team.

→

Browse trials by condition

Breast Cancer (423) Advanced Solid Tumors (187) Colorectal Cancer (179) Gastric Cancer (175) Hepatocellular Carcinoma (154) Advanced Solid Tumor (153) Non-Small Cell Lung Cancer (145) Solid Tumor (142) Acute Ischemic Stroke (140) Lung Cancer (135) Non-small Cell Lung Cancer (132) Pancreatic Cancer (131) Multiple Myeloma (128) Coronary Artery Disease (122) Prostate Cancer (110)

→

Browse trials by site location

Beijing (5576) Shanghai (3879) Guangzhou (3345) Hangzhou (1819) Wuhan (1343) Chengdu (1307) Nanjing (1211) Changsha (1154) Chongqing (1078) Fuzhou (1040) Tianjin (934) Zhengzhou (931) Hefei (896) Jinan (783) Changchun (639)

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.